{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":57,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":57,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"bc6c5d71f5d0","filters":{"venue":"Drugs of today"}},"results":[{"id":"W2985958489","doi":"10.1358/dot.2019.55.10.3045038","title":"Viltolarsen for the treatment of Duchenne muscular dystrophy","year":2019,"lang":"en","type":"review","venue":"Drugs of today","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Duchenne muscular dystrophy; Dystrophin; Exon skipping; Exon; Medicine; Morpholino; RNA splicing; Muscular dystrophy; Alternative splicing; Bioinformatics; Genetics; Internal medicine; Gene; Gene knockdown; RNA; Biology","authors":[{"name":"Rohini Roy Roshmi","is_ca":true},{"name":"Toshifumi Yokota","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03020348874980639,"gpt":0.3216006072539669,"spread":0.2913971185041606,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009332265,0.0002501539,0.000840217,0.00003451513,0.00003516587,0.00000302484,0.000300317,0.0002903719,0.00001683975],"category_scores_gemma":[0.00002955532,0.0001493791,0.0009823282,0.00004909567,0.0001113067,0.000001154593,0.00004313281,0.00004417673,0.000006367406],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001040948,"about_ca_system_score_gemma":0.0001269919,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002374945,"about_ca_topic_score_gemma":0.00000259133,"domain_scores_codex":[0.9990672,0.00006555924,0.0003324567,0.0002985896,0.00006634387,0.0001698552],"domain_scores_gemma":[0.9988034,0.00009725532,0.0003146678,0.000691623,0.00006641111,0.00002664325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001265838,0.0003632015,0.00000278715,0.007417432,0.001636373,3.116716e-7,0.00007710884,0.000022253,0.001840779,0.0002746822,0.001335759,0.9869027],"study_design_scores_gemma":[0.0004330933,0.0007016425,0.000004439929,0.0002518408,0.0007858467,9.102894e-7,0.00002579913,0.000002104479,0.0009198847,0.00003217853,0.9966986,0.0001436795],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00100163,0.9972162,0.00006734725,0.00002063547,0.000230095,0.0009916878,0.0002209706,0.000002803376,0.0002486939],"genre_scores_gemma":[0.001496667,0.9970536,0.0001065217,0.0000160009,0.0001511837,0.0001644732,0.0004976132,0.00003031459,0.0004835754],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9953628,"threshold_uncertainty_score":0.6091504,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3047556542","doi":"10.1358/dot.2020.56.8.3159186","title":"Golodirsen for Duchenne muscular dystrophy","year":2020,"lang":"en","type":"article","venue":"Drugs of today","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Exon skipping; Duchenne muscular dystrophy; Exon; Medicine; Dystrophin; Morpholino; Muscular dystrophy; Gene; Bioinformatics; Genetics; Antisense therapy; Internal medicine; Gene knockdown; Biology; Oligonucleotide; Alternative splicing","authors":[{"name":"Saeed Anwar","is_ca":true},{"name":"Toshifumi Yokota","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0094307765891266,"gpt":0.2321511105201688,"spread":0.2227203339310422,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005269606,0.00008847899,0.0001301195,0.00001067867,0.00003172455,0.00000291413,0.0001486539,0.00009416066,0.00002688166],"category_scores_gemma":[0.00009886928,0.00008377368,0.0001353637,0.00003660406,0.00006575133,0.000001891895,0.00005515642,0.00003490421,0.000008031533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000001609704,"about_ca_system_score_gemma":0.0000255541,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007620752,"about_ca_topic_score_gemma":0.000001044398,"domain_scores_codex":[0.9994496,0.00002039234,0.0001241169,0.0002202461,0.00004497959,0.0001407046],"domain_scores_gemma":[0.999647,0.00001095656,0.00005395381,0.0001725862,0.00005244076,0.00006308496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003932115,0.00004875636,0.0001829293,0.00007461049,0.0000810476,4.087039e-7,0.0001585335,0.0001445136,0.9841633,0.0007432917,0.01204001,0.001969328],"study_design_scores_gemma":[0.002536278,0.00130169,0.001842251,0.00001069151,0.00006264455,0.000001002427,0.0004186043,0.000243114,0.6516961,0.001099039,0.3404003,0.0003883107],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945045,0.000435761,0.001508198,0.001646821,0.00008299381,0.0001958629,0.00004821484,0.00001134768,0.001566375],"genre_scores_gemma":[0.9976798,0.00003502857,0.0009200905,0.0009222474,0.0001781424,0.00002155494,0.000132948,0.00001244543,0.00009768926],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3324673,"threshold_uncertainty_score":0.3416192,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2701201582","doi":"10.1358/dot.2017.53.5.2613690","title":"Brodalumab: The first anti-IL-17 receptor agent for psoriasis","year":2017,"lang":"en","type":"review","venue":"Drugs of today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Secukinumab; Ixekizumab; Psoriasis Area and Severity Index; Psoriasis; Ustekinumab; Psoriatic arthritis; Dermatology; Interleukin 17; Clinical trial; Erythroderma; Immunology; Internal medicine; Adalimumab; Immune system; Disease","authors":[{"name":"L. Puig","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06135471088143997,"gpt":0.3181274239703031,"spread":0.2567727130888632,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000777735,0.0006085074,0.002158101,0.0001497906,0.0007130123,0.00003962417,0.001321061,0.0008230534,0.0005078084],"category_scores_gemma":[0.000210491,0.0003722766,0.001582914,0.00009446677,0.000286202,0.00006739952,0.000198735,0.0002656854,0.0008548526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009324025,"about_ca_system_score_gemma":0.0002061436,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007704298,"about_ca_topic_score_gemma":0.00002427589,"domain_scores_codex":[0.9977806,0.0002866056,0.0007594603,0.0005891463,0.00006749624,0.0005167152],"domain_scores_gemma":[0.9964186,0.0009035116,0.001116674,0.001430285,0.0001048227,0.00002613255],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003475301,0.0001133031,0.000006157216,0.002277375,0.001640377,0.000001067894,0.0001970491,1.155853e-7,0.00001040716,0.0001152606,0.1268715,0.8687326],"study_design_scores_gemma":[0.0008680641,0.0001056996,0.00001393731,0.0026928,0.002708789,0.00001232394,0.00003640499,4.92285e-8,0.0003009151,0.000019578,0.9928656,0.0003758614],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003875471,0.9893664,0.0000093234,0.000310532,0.004518044,0.001666115,0.002116552,0.0000508666,0.001923483],"genre_scores_gemma":[0.00006155168,0.978457,0.00008611505,0.00005490518,0.0003625709,0.0005987535,0.00129038,0.00007357537,0.01901514],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8683568,"threshold_uncertainty_score":0.9999231,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3161179238","doi":"10.1358/dot.2021.57.5.3264119","title":"Remimazolam: a short-acting benzodiazepine for procedural sedation","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Benzodiazepine; Sedation; Anesthesia; Internal medicine","authors":[{"name":"David M. Paton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0334317832994494,"gpt":0.3167641908888383,"spread":0.2833324075893889,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001442859,0.00008548268,0.0002271081,0.00003914754,0.00004381587,0.000006722037,0.00004167586,0.00005147768,0.0001130833],"category_scores_gemma":[0.0003258423,0.00007642786,0.00009849439,0.0001167602,0.00002183349,0.00008495423,0.00001682168,0.00006546683,0.000007212117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002828636,"about_ca_system_score_gemma":0.000116379,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005842432,"about_ca_topic_score_gemma":0.000002506599,"domain_scores_codex":[0.9992836,0.00001656911,0.0002168576,0.0001773298,0.0001585519,0.000147141],"domain_scores_gemma":[0.9993889,0.00007507586,0.00006665961,0.0001541573,0.0002562587,0.00005890114],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001428224,0.001162612,0.09403571,0.002683463,0.0005269229,0.0001637211,0.01181676,0.00003201433,0.6695428,0.003355503,0.03136715,0.1838851],"study_design_scores_gemma":[0.003032486,0.0004606968,0.05658183,0.0005614629,0.0003102041,0.0001081597,0.004914958,0.002175354,0.849622,0.0003623165,0.08151599,0.0003545304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861033,0.000151959,0.001735588,0.004356787,0.0000867232,0.0004615263,0.00001154316,0.00003960051,0.007053006],"genre_scores_gemma":[0.9909452,0.00001385075,0.00538246,0.0007543685,0.0001311227,0.0000261582,0.0002206638,0.00001653262,0.002509692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1835305,"threshold_uncertainty_score":0.3116638,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1968779439","doi":"10.1358/dot.2005.41.4.908565","title":"Statin-associated neuromyotoxicity","year":2005,"lang":"en","type":"article","venue":"Drugs of today","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Geranylgeranyl pyrophosphate; Myopathy; Rhabdomyolysis; Statin; Mevalonate pathway; Disease; Bioinformatics; Internal medicine; Prenylation; Biochemistry; Biology","authors":[{"name":"Steven K. Baker","is_ca":true},{"name":"Mark A. Tarnopolsky","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01048578839546409,"gpt":0.259453654406713,"spread":0.2489678660112489,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004343356,0.00008347995,0.0002954575,0.00004673119,0.00003396534,0.000004134775,0.00005921962,0.00005775137,0.000162804],"category_scores_gemma":[0.0001312579,0.00007009818,0.0001909553,0.0001258454,0.00003035067,0.0000454839,0.00002411394,0.0001327869,0.00004054377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005627866,"about_ca_system_score_gemma":0.00008972387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000211541,"about_ca_topic_score_gemma":0.0000156413,"domain_scores_codex":[0.9990031,0.00005194835,0.0002230326,0.0001450122,0.0003850585,0.0001919138],"domain_scores_gemma":[0.9993615,0.00002588699,0.00007986093,0.000322722,0.0000958337,0.000114248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0004313076,0.002497696,0.02472533,0.0007753531,0.001213013,0.0000861166,0.004669521,0.0001534608,0.02992386,0.002000575,0.04569327,0.8878305],"study_design_scores_gemma":[0.01013611,0.001085291,0.469063,0.0003883,0.0004530697,0.00005817467,0.0005209312,0.001002047,0.1719745,0.0002885043,0.3444703,0.0005597337],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9842914,0.000295831,0.00005756308,0.00287362,0.00006775853,0.000295978,0.00001376844,0.00005528802,0.01204878],"genre_scores_gemma":[0.9965099,0.00005627337,0.0008568357,0.001254142,0.0001798647,0.000008153416,0.00001457901,0.00001544225,0.001104808],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8872707,"threshold_uncertainty_score":0.285852,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045159955","doi":"10.1358/dot.2004.40.5.850489","title":"Levocetirizine: A new selective H1 receptor antagonist for use inallergic disorders","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Levocetirizine; Cetirizine; Medicine; Pharmacology; Histamine; Histamine H1 receptor; Antagonist; Pharmacokinetics; Receptor; Internal medicine","authors":[{"name":"James H. Day","is_ca":true},{"name":"Anne K. Ellis","is_ca":false},{"name":"Elizabeth Rafeiro","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03495536806048386,"gpt":0.3191909200766362,"spread":0.2842355520161523,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001664809,0.000476334,0.001988281,0.0002405203,0.00009288157,0.00003439956,0.0001529037,0.0004109282,0.0001196944],"category_scores_gemma":[0.0002750898,0.0003909035,0.0007974714,0.000395925,0.00009505654,0.0001114547,0.00004275014,0.0003284576,0.00004116288],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002906565,"about_ca_system_score_gemma":0.001463059,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002526015,"about_ca_topic_score_gemma":0.000030819,"domain_scores_codex":[0.997956,0.00006627334,0.0007909926,0.000517684,0.0003284766,0.0003406118],"domain_scores_gemma":[0.9983451,0.0002561598,0.0005764883,0.0003831957,0.0002415502,0.000197491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002136248,0.0002746235,0.000007051219,0.0197654,0.0007705464,0.000008240605,0.0007084369,0.000006263719,0.000005353733,0.001250946,0.04718941,0.9298001],"study_design_scores_gemma":[0.001590028,0.0003739559,0.000008594276,0.01428461,0.0008108721,0.00003312855,0.00006629566,0.00001197303,0.00001179578,0.0001824264,0.9822648,0.0003615812],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004160453,0.9929608,0.0008766622,0.0005386776,0.0004570269,0.002568961,0.0001842905,0.0000764157,0.002295612],"genre_scores_gemma":[0.00007311561,0.9851433,0.004450268,0.0001041967,0.0003882303,0.00006468762,0.001621,0.0001218063,0.008033367],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9350753,"threshold_uncertainty_score":0.9998543,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4253026915","doi":"10.1358/dot.2003.39.4.799404","title":"Aminoglycoside ototoxicity","year":2003,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Aminoglycoside; Ototoxicity; Medicine; Pharmacology; Toxicity; Antibiotics; Gentamicin; Hearing loss; Internal medicine; Genetics; Biology; Audiology; Chemotherapy","authors":[{"name":"Duane Bates","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09214801784366826,"gpt":0.3536444778535877,"spread":0.2614964600099194,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000521121,0.000576473,0.001772028,0.0002991881,0.0001065252,0.00005648989,0.001109587,0.0004456288,0.0002587187],"category_scores_gemma":[0.001386266,0.0005266952,0.0006171796,0.0006662756,0.000247871,0.00007418994,0.0003208298,0.0007007747,0.0008051504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000136077,"about_ca_system_score_gemma":0.0004581003,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002553373,"about_ca_topic_score_gemma":0.000002228341,"domain_scores_codex":[0.9961383,0.0005577967,0.001063307,0.0009072672,0.0006879278,0.0006454253],"domain_scores_gemma":[0.997068,0.0006421973,0.0007327861,0.001271023,0.00006623643,0.0002197606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000003885192,0.0001974805,0.00000521059,0.01260013,0.0000295436,0.00004861029,0.0002027218,0.000003959874,0.000875934,0.001219873,0.005073914,0.9797387],"study_design_scores_gemma":[0.0001122545,0.000044199,0.000002099917,0.002784687,0.0001405927,0.00004353932,0.000005539004,0.000003430086,0.01016541,0.00008412843,0.9861522,0.0004618905],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002544988,0.9639313,0.00003573934,0.00001861512,0.0007558924,0.001108146,0.0001009688,0.0001013146,0.03369356],"genre_scores_gemma":[0.0002067804,0.9930875,0.0006105017,0.0002953965,0.000136156,0.00005842057,0.000007891877,0.0001192038,0.005478208],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9810783,"threshold_uncertainty_score":0.9999728,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2317463698","doi":"10.1358/dot.2000.36.2-3.568786","title":"Sildenafil citrate (Viagra(R))","year":2000,"lang":"en","type":"article","venue":"Drugs of today","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Centre","funders":"","keywords":"Sildenafil; Medicine; Cyclic guanosine monophosphate; Erectile dysfunction; cGMP-specific phosphodiesterase type 5; Pharmacology; Erectile function; Phosphodiesterase; Phosphodiesterase inhibitor; Internal medicine; Urology; Biochemistry; Enzyme","authors":[{"name":"Gerald Brock","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01380552254417854,"gpt":0.2656979121947541,"spread":0.2518923896505755,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001036276,0.0000929122,0.0002201363,0.0000637491,0.00005230112,0.000005187108,0.00003586792,0.0000460397,0.008781672],"category_scores_gemma":[0.0000359408,0.00007260166,0.0000861095,0.000171856,0.0000627429,0.00004395977,0.00001013807,0.0000856592,0.0008689644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001410866,"about_ca_system_score_gemma":0.00002531966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005465736,"about_ca_topic_score_gemma":0.000001597275,"domain_scores_codex":[0.9992852,0.00001513993,0.000200585,0.0001510317,0.0002130201,0.0001349984],"domain_scores_gemma":[0.9995572,0.00004526323,0.00003543841,0.0001954187,0.00008539113,0.00008127366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002351135,0.0009656468,0.03338716,0.0002389163,0.0006339329,0.00004627643,0.003997969,0.00007550883,0.01519332,0.003275315,0.5650018,0.374833],"study_design_scores_gemma":[0.00248346,0.000410579,0.05222521,0.00005693719,0.0001117346,0.00003388293,0.001028845,0.00005236521,0.01003712,0.0002483684,0.933134,0.0001774645],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6092554,0.0004432493,0.00003656681,0.002015656,0.0003412706,0.0001318306,0.000005275048,0.0001098871,0.3876608],"genre_scores_gemma":[0.8656915,0.0001555317,0.0001804471,0.002017903,0.0001773427,0.000008334574,0.00001072939,0.00001176593,0.1317464],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3746555,"threshold_uncertainty_score":0.999909,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4200087363","doi":"10.1358/dot.2021.57.12.3352740","title":"Casimersen for Duchenne muscular dystrophy","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Medicine; Exon skipping; Duchenne muscular dystrophy; Dystrophin; Exon; Muscular dystrophy; Population; Antisense therapy; Bioinformatics; Clinical trial; Pharmacology; Internal medicine; Genetics; Gene; Oligonucleotide; Biology; Alternative splicing","authors":[{"name":"Harry Wilton-Clark","is_ca":true},{"name":"Tsukasa Yokota","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005900815163805081,"gpt":0.2427122663161498,"spread":0.2368114511523448,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006570451,0.00008073893,0.0001203258,0.00001381792,0.0000385471,0.000003376545,0.00008964989,0.00009782893,0.00004480535],"category_scores_gemma":[0.00008801068,0.00008066053,0.0001450117,0.00003995994,0.0000586123,0.000001663118,0.00005269769,0.00003072192,0.000004248904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000002534623,"about_ca_system_score_gemma":0.00005936273,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001236225,"about_ca_topic_score_gemma":0.000006624639,"domain_scores_codex":[0.9994482,0.0000274978,0.0001156084,0.0002172712,0.00004555401,0.0001458569],"domain_scores_gemma":[0.9995272,0.00001377031,0.00004510764,0.0002670162,0.0001089166,0.00003800124],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001137164,0.00007725123,0.0001444128,0.00004499442,0.0000947691,0.000001711772,0.00005683845,0.00007612749,0.9918413,0.0007627495,0.00443444,0.002351737],"study_design_scores_gemma":[0.001068667,0.0001938405,0.001253632,0.000008354922,0.00003792848,0.000003529422,0.0003543584,0.00002635265,0.8682781,0.0009424887,0.1276564,0.0001762591],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995238,0.0009572222,0.000739439,0.0003479046,0.0001566429,0.0001046776,0.00003998676,0.000005603307,0.002410497],"genre_scores_gemma":[0.9974068,0.00006989207,0.001208558,0.0002650451,0.0001102947,0.0000185226,0.0002396023,0.00001163959,0.0006696613],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1235631,"threshold_uncertainty_score":0.3289241,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2942062551","doi":"10.1358/dot.2019.55.4.2958476","title":"Encorafenib and binimetinib for the treatment of BRAFV600E/K-mutated melanoma","year":2019,"lang":"en","type":"review","venue":"Drugs of today","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Melanoma; MAPK/ERK pathway; Metastatic melanoma; V600E; Cancer research; Oncology; Kinase; Pharmacology; Mutation; Internal medicine; Biology; Genetics","authors":[{"name":"April A. N. Rose","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04074034639323368,"gpt":0.3182639523817377,"spread":0.277523605988504,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001640626,0.0002940615,0.0009709999,0.00005510013,0.00003428814,0.000007779531,0.0002413012,0.0002784668,0.00001391288],"category_scores_gemma":[0.00003773209,0.00017175,0.0004958543,0.00006324753,0.0000930458,0.000001355437,0.0000575873,0.00004225244,0.000005411778],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001056369,"about_ca_system_score_gemma":0.0001692058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002629953,"about_ca_topic_score_gemma":0.000004151544,"domain_scores_codex":[0.9988687,0.00007058049,0.000446408,0.0003431583,0.0000905817,0.0001805841],"domain_scores_gemma":[0.9987227,0.0001963721,0.0004210942,0.0005441022,0.00006951325,0.00004627243],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005805655,0.0001342631,0.00001269964,0.004477916,0.0007244644,6.406922e-7,0.0001123598,5.592078e-7,0.001427988,0.0001280815,0.00102889,0.9918941],"study_design_scores_gemma":[0.0005617005,0.001286604,0.000005025081,0.0004350976,0.0008769166,0.000008492454,0.00002631469,0.000003086563,0.009883668,0.00001176365,0.9867259,0.0001754305],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001900736,0.9953208,0.00003871343,0.00001719992,0.0002678185,0.001279468,0.000521666,0.000004408757,0.0006492175],"genre_scores_gemma":[0.001099587,0.9959205,0.0002132488,0.00001056019,0.0001587375,0.0001398287,0.0005437486,0.00003913536,0.001874692],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9917186,"threshold_uncertainty_score":0.700376,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2041935038","doi":"10.1358/dot.2008.44.7.1227147","title":"Desvenlafaxine succinate for major depressive disorder","year":2008,"lang":"en","type":"review","venue":"Drugs of today","topic":"Treatment of Major Depression","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Venlafaxine; Internal medicine; Adverse effect; Pharmacology; Antidepressant; Vasomotor; Endocrinology","authors":[{"name":"Beth Sproule","is_ca":true},{"name":"Monica Hazra","is_ca":false},{"name":"Bruce G. Pollock","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02766957565775824,"gpt":0.3371435443253235,"spread":0.3094739686675653,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001145162,0.0006331255,0.002805012,0.0003298949,0.0001054433,0.000009225957,0.0003104094,0.0004747385,0.0001555746],"category_scores_gemma":[0.0002419029,0.0004374968,0.001279052,0.0002224203,0.0001008162,0.00007731751,0.0001364185,0.0003140004,0.00007671224],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001318912,"about_ca_system_score_gemma":0.0002996283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004374726,"about_ca_topic_score_gemma":0.000003181806,"domain_scores_codex":[0.997566,0.00008286299,0.0008434614,0.0006374925,0.0004369151,0.0004332387],"domain_scores_gemma":[0.9974935,0.0005040723,0.0007274382,0.0008974494,0.0001840416,0.0001934986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001046508,0.000459174,0.00009323088,0.02030717,0.0006728055,0.00006235945,0.0000743752,4.75742e-7,0.000002920655,0.00004780459,0.01070457,0.9674705],"study_design_scores_gemma":[0.003400226,0.0002911998,0.00007849506,0.01778165,0.002807773,0.000181391,0.000009603959,0.000002903493,0.0001125294,0.0000461305,0.9749373,0.0003507735],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009237764,0.9938908,0.00008622305,0.0001516483,0.0002988205,0.003142826,0.0002821408,0.0000937667,0.001961373],"genre_scores_gemma":[0.0001231073,0.9888833,0.001979961,0.00003314095,0.0002504228,0.0006287337,0.0008531685,0.0001709548,0.007077235],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9671197,"threshold_uncertainty_score":0.9998077,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4253652799","doi":"10.1358/dot.2011.47.10.1656503","title":"Boceprevir","year":2011,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hepatitis C virus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Boceprevir; Medicine; Ribavirin; Pharmacology; Hepatitis C virus; Telaprevir; Virology; Internal medicine; Virus","authors":[{"name":"S.A. Rizza","is_ca":false},{"name":"R. Talwani","is_ca":false},{"name":"V Nehra","is_ca":false},{"name":"Z. Temesgen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1213898191552022,"gpt":0.4169331912826664,"spread":0.2955433721274641,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004595811,0.0002772785,0.002101272,0.000308432,0.00002106222,0.000006745262,0.0003400759,0.0003272966,0.002525353],"category_scores_gemma":[0.0003088868,0.0002044659,0.000666109,0.0002875006,0.0001165398,0.00004000471,0.0001646261,0.0005551833,0.001994516],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009063119,"about_ca_system_score_gemma":0.0005887087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001186012,"about_ca_topic_score_gemma":0.00000194597,"domain_scores_codex":[0.9981793,0.0001392341,0.000636491,0.0003289172,0.0003959699,0.0003201113],"domain_scores_gemma":[0.9984456,0.0001393426,0.0002330975,0.0008425184,0.0001294281,0.0002100418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000004760956,0.00006188888,0.00001339959,0.03030243,0.0001587379,0.00002218771,0.00007416774,9.68015e-10,3.045787e-7,0.0002181124,0.01006793,0.9590761],"study_design_scores_gemma":[0.0001621306,0.00008619216,0.000004584395,0.0180083,0.0004991863,0.00001321088,0.000003753278,3.001387e-7,0.0000101679,0.00001958794,0.9810429,0.0001496806],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002329713,0.8387399,0.000002275926,0.00002328427,0.000107516,0.0007593662,0.00005267465,0.00003276056,0.1602799],"genre_scores_gemma":[0.0000116403,0.9902996,0.0003162515,0.00003989232,0.0001883118,0.00007631941,0.00009419634,0.00007771733,0.008896001],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.970975,"threshold_uncertainty_score":0.9987826,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2064695702","doi":"10.1358/dot.2002.38.1.677133","title":"Medical backgrounder on varicocele","year":2002,"lang":"en","type":"review","venue":"Drugs of today","topic":"Sperm and Testicular Function","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Varicocele; Medicine; Hydrocele; Male infertility; Semen quality; Infertility; Urology; Semen; Surgery; Andrology; Pregnancy; Biology","authors":[{"name":"Peter Chan","is_ca":true},{"name":"Marc Goldstein","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05104752085932522,"gpt":0.329940138467689,"spread":0.2788926176083638,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002407815,0.0002656244,0.001300873,0.0001749016,0.0000254323,0.000006829311,0.000134613,0.0004692805,0.006061676],"category_scores_gemma":[0.0003540792,0.0001813667,0.0005031783,0.0002321151,0.0000622446,0.000026281,0.00003722797,0.0004759602,0.001066077],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009390308,"about_ca_system_score_gemma":0.0002055628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001643756,"about_ca_topic_score_gemma":3.840279e-7,"domain_scores_codex":[0.9982442,0.00006130746,0.000459249,0.0003022944,0.0007382557,0.0001947102],"domain_scores_gemma":[0.9988292,0.0002903553,0.0001845446,0.0004421764,0.00006122445,0.0001924337],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00000566223,0.0003037059,0.000003158082,0.007469855,0.0001723847,0.00006482683,0.00001938067,4.291631e-8,9.011974e-8,0.0009132033,0.01615454,0.9748932],"study_design_scores_gemma":[0.0003786438,0.0001978468,0.00001030567,0.01297795,0.0009912914,0.0001677387,0.000006865404,0.00001299836,0.000001262712,0.00003005972,0.9850764,0.0001486859],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000006593219,0.9409012,0.00003550169,0.000159897,0.0005298709,0.000340771,0.000006881522,0.00005031173,0.05796896],"genre_scores_gemma":[0.0000659271,0.9935886,0.0001009146,0.0002749809,0.0005498827,0.00002155693,0.0001195971,0.00004901032,0.005229522],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9747444,"threshold_uncertainty_score":0.9997117,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W183877133","doi":"10.1358/dot.2012.48.12.1885866","title":"Remestemcel-L, the first cellular therapy product for the treatmentof graft-versus-host disease","year":2012,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Mesenchymal stem cell; Graft-versus-host disease; Disease; Transplantation; Cell therapy; Front line; Stem cell; Immunology; Surgery; Internal medicine; Pathology","authors":[{"name":"Andrew Daly","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07970850809014411,"gpt":0.3356937943612554,"spread":0.2559852862711113,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007378118,0.0005075713,0.001237153,0.00008611775,0.0002071712,0.00002524554,0.000432489,0.0001217187,0.0001187471],"category_scores_gemma":[0.00006278074,0.0002279497,0.000979332,0.000238043,0.0001679061,0.0000579819,0.00002670216,0.0002228677,0.00006268486],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001043144,"about_ca_system_score_gemma":0.0003287047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003569512,"about_ca_topic_score_gemma":0.000006251519,"domain_scores_codex":[0.9978282,0.0001330445,0.0007094835,0.0004322609,0.0005021054,0.0003949384],"domain_scores_gemma":[0.9963422,0.00150853,0.0004788338,0.001388003,0.0001193469,0.0001630351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001498797,0.0009363322,0.0001104254,0.0850956,0.003353848,0.00002865356,0.00298873,0.000001036538,0.0000182993,0.0008300925,0.005000588,0.9001376],"study_design_scores_gemma":[0.001701884,0.0001293346,0.00005622576,0.004994812,0.007617067,0.00001265594,0.00009281065,0.000003075107,0.0002004128,0.000007655456,0.9849643,0.0002198347],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004095759,0.9891151,0.00004616664,0.002011299,0.0008608684,0.006989333,0.0001951277,0.0000438783,0.0006972705],"genre_scores_gemma":[0.001439229,0.9937261,0.00007704672,0.00007718446,0.0007330973,0.00124175,0.0003918117,0.0001135813,0.00220019],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9799637,"threshold_uncertainty_score":0.9295518,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1995684830","doi":"10.1358/dot.2006.42.3.957358","title":"Clinical experience with erlotinib in non-small-cell lung cancer(NSCLC)","year":2006,"lang":"en","type":"review","venue":"Drugs of today","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Erlotinib; Medicine; Lung cancer; Epidermal growth factor receptor; Erlotinib Hydrochloride; Oncology; Tyrosine kinase; EGFR inhibitors; Cancer research; Cancer; T790M; Tyrosine-kinase inhibitor; Clinical trial; Internal medicine; Pharmacology; Gefitinib; Receptor","authors":[{"name":"Enriqueta Felip","is_ca":false},{"name":"Rafael Rosell","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03141548310013683,"gpt":0.4158838494868783,"spread":0.3844683663867415,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001700208,0.0003595098,0.00181651,0.0001733919,0.00003286616,0.00001127663,0.0001936689,0.0002372781,0.0000884835],"category_scores_gemma":[0.00001668293,0.0002385182,0.0003606473,0.0003609871,0.0001116751,0.00004664743,0.00004376422,0.000368658,0.00001176878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002532485,"about_ca_system_score_gemma":0.001300595,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001507657,"about_ca_topic_score_gemma":0.000199986,"domain_scores_codex":[0.9979218,0.00006403841,0.0009522676,0.0005053582,0.0002573578,0.0002991466],"domain_scores_gemma":[0.9986116,0.0001796315,0.0004965313,0.0004896022,0.00009171938,0.0001309032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005453591,0.0009253531,0.01695101,0.01969946,0.0004202751,0.0001295113,0.001573378,0.000007215901,4.345445e-7,0.00002260513,0.003274092,0.9569421],"study_design_scores_gemma":[0.003196487,0.0002817439,0.00173219,0.03975999,0.003413501,0.00001514278,0.00020517,0.00001307751,0.000008889143,0.000001545915,0.950982,0.0003902106],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002232411,0.9795076,0.00001969594,0.00005463032,0.000295468,0.00191151,0.00008108901,0.00002504519,0.01587254],"genre_scores_gemma":[0.001374816,0.990953,0.0008837573,0.00007655138,0.0002504053,0.0007016641,0.0001697343,0.00006649225,0.005523578],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9565519,"threshold_uncertainty_score":0.972649,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2038264909","doi":"10.1358/dot.2003.39.8.799407","title":"Role of 5-HT receptors in treatment of overactive bladder","year":2003,"lang":"en","type":"review","venue":"Drugs of today","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Serotonergic; Overactive bladder; Urination; Reflex; Duloxetine; Urology; Urinary bladder; Urethral sphincter; Receptor; Internal medicine; Endocrinology; Pharmacology; Serotonin; Urethra; Urinary system; Pathology","authors":[{"name":"Sabri Mahmoud Khaled","is_ca":true},{"name":"Mostafa Elhilali","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04058001073595981,"gpt":0.3736951977028197,"spread":0.3331151869668599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002680457,0.0002941534,0.002235127,0.0004539379,0.00001058946,0.00000213107,0.0001173095,0.0002317452,0.0008148166],"category_scores_gemma":[0.00005346208,0.00021167,0.0005259223,0.0004223562,0.0001113989,0.00004458229,0.00003523691,0.0002259572,0.00001916035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000200461,"about_ca_system_score_gemma":0.0006639599,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003132678,"about_ca_topic_score_gemma":0.000005414819,"domain_scores_codex":[0.998007,0.0002395632,0.0007881251,0.0002909891,0.0004105651,0.0002637769],"domain_scores_gemma":[0.9985603,0.0003441092,0.000406417,0.0004525348,0.0001375626,0.0000990464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001589547,0.001425439,0.0001627273,0.009529376,0.000718471,0.00001507943,0.001472483,4.40433e-7,0.0000309958,0.00004576942,0.0004235713,0.9860167],"study_design_scores_gemma":[0.00104941,0.001557516,0.00006002096,0.005493904,0.000575858,0.0000164537,0.0003925761,8.189283e-7,0.001285963,0.00005208557,0.9893666,0.0001488239],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006802391,0.9696228,1.772416e-7,0.00002184582,0.00006974072,0.001191416,0.0001250896,0.000004739745,0.02828396],"genre_scores_gemma":[0.0006460618,0.9954362,0.000126386,0.00000338368,0.00003838828,0.00006458643,0.0001332092,0.00004081614,0.00351096],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.988943,"threshold_uncertainty_score":0.892167,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2376717750","doi":"10.1358/dot.2013.49.12.2067249","title":"Simeprevir for the treatment of genotype 1 chronic hepatitis Cvirus","year":2013,"lang":"en","type":"article","venue":"Drugs of today","topic":"Hepatitis C virus research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Simeprevir; Ribavirin; Medicine; Pegylated interferon; Virology; Hepatitis C virus; Genotype; Protease inhibitor (pharmacology); Interferon; Internal medicine; Pharmacology; Virus; Viral load; Biology","authors":[{"name":"Rohit Talwani","is_ca":false},{"name":"Emily L. Heil","is_ca":false},{"name":"Bruce L. Gilliam","is_ca":false},{"name":"Zelalem Temesgen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02708515269192192,"gpt":0.3213115087311132,"spread":0.2942263560391913,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001416824,0.0001109303,0.0003228112,0.00006410621,0.00004667381,0.000007171642,0.0001393521,0.00005951884,0.001487568],"category_scores_gemma":[0.0001080574,0.00006737033,0.0001727842,0.0001146764,0.0001288266,0.00005023852,0.00002472178,0.00005358967,0.000183717],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001711318,"about_ca_system_score_gemma":0.0001813009,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007474995,"about_ca_topic_score_gemma":0.0002837107,"domain_scores_codex":[0.9990039,0.00003505799,0.0002856505,0.0001563697,0.0002739843,0.0002450179],"domain_scores_gemma":[0.9987078,0.0004076562,0.00008794542,0.000486388,0.0002276494,0.00008250099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001056505,0.0004250241,0.01932523,0.0002759616,0.0003741362,0.000002500198,0.001059681,0.00001699152,0.02125551,0.0003746626,0.008030368,0.9487543],"study_design_scores_gemma":[0.003957648,0.00509089,0.06689584,0.0001575573,0.0002485477,0.000002314066,0.00008719882,0.004378816,0.2103232,0.0002586593,0.7084094,0.000189951],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9780219,0.008670502,0.0002055959,0.002633366,0.000153364,0.003200869,0.0001101955,0.00002833537,0.006975858],"genre_scores_gemma":[0.9887009,0.006023518,0.000606888,0.00007436613,0.0001719452,0.000353388,0.00002004083,0.00002485901,0.004024133],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9485644,"threshold_uncertainty_score":0.9994252,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079795343","doi":"10.1358/dot.2011.47.5.1584113","title":"Psychosis in Parkinson's disease: Therapeutic options","year":2011,"lang":"en","type":"review","venue":"Drugs of today","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Quetiapine; Ziprasidone; Medicine; Psychosis; Clozapine; Olanzapine; Risperidone; Rivastigmine; Parkinson's disease; Psychiatry; Donepezil; Antipsychotic; Amantadine; Amisulpride; Disease; Schizophrenia (object-oriented programming); Intensive care medicine; Dementia; Pharmacology; Internal medicine","authors":[{"name":"Mehrul Hasnain","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05147819620287031,"gpt":0.3382877219087331,"spread":0.2868095257058628,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001597092,0.0004601882,0.001619331,0.0004367626,0.00003731637,0.0000103505,0.0002316941,0.0002164356,0.0004432912],"category_scores_gemma":[0.00002053669,0.0003490491,0.0008448406,0.0003724982,0.00006068108,0.0000546153,0.00005227118,0.0002498816,0.0001774064],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001392527,"about_ca_system_score_gemma":0.0002916468,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000641006,"about_ca_topic_score_gemma":0.000004516902,"domain_scores_codex":[0.9981649,0.0001250246,0.0005645165,0.0005381707,0.0002693227,0.0003380518],"domain_scores_gemma":[0.9984533,0.00006344019,0.0003083196,0.0007786358,0.00004854414,0.0003477194],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006320487,0.00111188,0.0004475388,0.007112542,0.0005477477,0.00007180397,0.00007045495,6.617837e-8,1.837305e-7,0.001145662,0.0004875949,0.9889413],"study_design_scores_gemma":[0.0007485839,0.00007391976,0.002217214,0.01146609,0.003043199,0.000007021235,0.00001224217,0.000001897753,0.00000141181,0.0004138337,0.981759,0.0002555955],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007907385,0.9954528,0.00001009798,0.00005650843,0.0002544172,0.001139052,0.0002713405,0.00004620956,0.0026905],"genre_scores_gemma":[0.00267939,0.9950251,0.0002671663,0.00008134134,0.00008015119,0.0005001246,0.0002679339,0.00008210264,0.001016713],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9886857,"threshold_uncertainty_score":0.9998962,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988535187","doi":"10.1358/dot.2009.45.10.1417873","title":"Degarelix for the treatment of prostate cancer","year":2009,"lang":"en","type":"review","venue":"Drugs of today","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Testosterone (patch); Castration; Androgen deprivation therapy; Gonadotropin-releasing hormone; Hormone antagonist; Prostate; Management of prostate cancer; Orchiectomy; Hormone; Internal medicine; Urology; Oncology; Cancer; Endocrine system; Luteinizing hormone","authors":[{"name":"Laurence Klotz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06837846130566895,"gpt":0.4177318112487104,"spread":0.3493533499430415,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001361344,0.0002911343,0.001538382,0.0001220571,0.00005109726,0.00000662904,0.0001512187,0.0001329666,0.00006526964],"category_scores_gemma":[0.00001837261,0.0001309081,0.0007811742,0.000193671,0.000119834,0.00001893867,0.000015074,0.00009434287,0.000004931881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003067346,"about_ca_system_score_gemma":0.0008337317,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002125641,"about_ca_topic_score_gemma":0.00001019319,"domain_scores_codex":[0.9986842,0.00003421979,0.0004732822,0.0002556801,0.0002702891,0.0002823289],"domain_scores_gemma":[0.9986399,0.0003274191,0.0003215222,0.0004490557,0.0001837902,0.00007827404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001941054,0.0003376544,0.0000159782,0.01017091,0.0008719741,0.000004360088,0.0004548294,5.539046e-7,0.000001306941,0.0000243462,0.002452076,0.9854719],"study_design_scores_gemma":[0.001621443,0.001556761,0.00001456417,0.007578826,0.00275273,0.000003255004,0.00004227091,0.000003053025,0.0002687073,0.00002265921,0.9860308,0.0001049859],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003868321,0.9936038,0.00000141178,0.000581275,0.0001476899,0.004379474,0.0005255991,0.00001275048,0.0007093291],"genre_scores_gemma":[0.00003586627,0.9833924,0.00009053131,0.00001719436,0.0001900607,0.001242689,0.0002063182,0.00003890119,0.01478611],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9853669,"threshold_uncertainty_score":0.5338277,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2325941892","doi":"10.1358/dot.2000.36.2-3.568785","title":"Oral phentolamine (Vasomax(R))","year":2000,"lang":"en","type":"article","venue":"Drugs of today","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Centre","funders":"","keywords":"Phentolamine; Medicine; Sympatholytic; Anesthesia; Internal medicine; Blood pressure; Propranolol","authors":[{"name":"Gerald Brock","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01142971626322359,"gpt":0.26645212058433,"spread":0.2550224043211064,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000964043,0.00008103859,0.0002479229,0.00003525942,0.00003222022,0.000001834042,0.00004602433,0.00002575574,0.001009081],"category_scores_gemma":[0.00003072814,0.000054753,0.00008190409,0.000110565,0.0001068529,0.00003299527,0.00001876417,0.00006630081,0.0001607996],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001207482,"about_ca_system_score_gemma":0.0000163417,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005043856,"about_ca_topic_score_gemma":0.000001994227,"domain_scores_codex":[0.999365,0.00001100408,0.0001448529,0.0001635922,0.0001825949,0.0001329547],"domain_scores_gemma":[0.9996614,0.00001532392,0.00002496107,0.0001816933,0.00006878969,0.00004786764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001070394,0.001365859,0.03690834,0.0003126608,0.000753385,0.00007844807,0.006974519,0.00001157864,0.04057062,0.001356633,0.0215326,0.889065],"study_design_scores_gemma":[0.003098303,0.0007590342,0.4930479,0.0001553743,0.0002389232,0.00004453313,0.001384947,0.0000291896,0.06700711,0.001032863,0.4328827,0.0003191567],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8633316,0.001147274,0.00000144481,0.002422786,0.0000642848,0.0001056372,0.000004526178,0.0000276449,0.1328949],"genre_scores_gemma":[0.9654157,0.0001811762,0.0003558666,0.000117748,0.0001887886,0.000004422758,0.000006112434,0.000008161403,0.03372199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8887458,"threshold_uncertainty_score":0.9999042,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4212843950","doi":"10.1358/dot.2022.58.2.3367993","title":"Loteprednol etabonate: a formulation for short-term use in inflammatory flares in dry eye disease","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Corticosteroid; Pharmacokinetics; Ophthalmology; Pharmacology; Internal medicine","authors":[{"name":"David M. Paton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01464491434465334,"gpt":0.2691281263938503,"spread":0.2544832120491969,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002494935,0.0001050409,0.0002231678,0.0002128329,0.00003654038,0.00000943117,0.00008353839,0.00004074959,0.00005597976],"category_scores_gemma":[0.00008424772,0.0001077406,0.0001094703,0.0001370183,0.0000113907,0.00018497,0.00007684919,0.0001568047,0.000002036522],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001087473,"about_ca_system_score_gemma":0.0001167976,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009373919,"about_ca_topic_score_gemma":0.0001276899,"domain_scores_codex":[0.9990072,0.00004396091,0.000308227,0.0001940557,0.0002504213,0.0001961925],"domain_scores_gemma":[0.9994943,0.00006810283,0.00005564986,0.0002663117,0.00004107369,0.0000746098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007537221,0.0001752464,0.9893652,0.000144011,0.00001885695,0.00005088537,0.001263452,0.0004018128,0.004446025,0.0004159641,0.00001501407,0.002949864],"study_design_scores_gemma":[0.001891215,0.00008505773,0.990538,0.00009573076,0.0000406228,9.908999e-8,0.0004680392,0.002443812,0.001466522,0.0001653548,0.002682786,0.0001227487],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982579,0.0003797018,0.00002880052,0.0002948918,0.00008878252,0.0007853906,0.00005647741,0.00002328073,0.00008474654],"genre_scores_gemma":[0.9990351,0.00001688925,0.0001154114,0.000140634,0.00002683947,0.000139103,0.0001230581,0.00002183625,0.0003810858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002979503,"threshold_uncertainty_score":0.4393536,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2020779524","doi":"10.1358/dot.2004.40.10.863742","title":"Gefitinib: Current status in the treatment of non-small cell lungcancer","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Gefitinib; Medicine; Lung cancer; Tolerability; Oncology; Epidermal growth factor receptor; Internal medicine; Chemotherapy; Tyrosine-kinase inhibitor; Cancer; Adverse effect","authors":[{"name":"Adnan Tanovı́c","is_ca":false},{"name":"Vicente Alfaro","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03334470967723603,"gpt":0.3830884928690895,"spread":0.3497437831918535,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000857562,0.0003341268,0.001388689,0.0001840847,0.00002372017,0.000006490142,0.0001372685,0.0001098254,0.00007013006],"category_scores_gemma":[0.000006477615,0.0001797232,0.000546474,0.0002728607,0.00005949388,0.00002093292,0.0000140242,0.0001445696,0.00001724284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007666033,"about_ca_system_score_gemma":0.001451057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001085032,"about_ca_topic_score_gemma":0.00006344928,"domain_scores_codex":[0.9984857,0.00005541494,0.0006478372,0.0002828302,0.0002502808,0.000277979],"domain_scores_gemma":[0.9987848,0.0001447629,0.0004278536,0.0004970867,0.00006901331,0.00007642859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001532276,0.001909788,0.0001437374,0.01809927,0.0002674476,0.00001509527,0.004389139,0.000005347261,3.98505e-7,0.0000494127,0.0002075746,0.9748974],"study_design_scores_gemma":[0.002297254,0.0006046097,0.0002494515,0.01465147,0.003314219,0.000004445058,0.0002145822,6.500628e-7,0.00002644151,0.00001584848,0.9784815,0.0001395148],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006766252,0.9906311,0.000003994742,0.00004864819,0.0002841002,0.002111855,0.0003762784,0.000008394004,0.005858974],"genre_scores_gemma":[0.001080031,0.9971522,0.0002037882,0.00001573856,0.0001156579,0.0004672395,0.000394207,0.00003657075,0.0005345742],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9782739,"threshold_uncertainty_score":0.7328901,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3006524053","doi":"10.1358/dot.2020.56.1.3069863","title":"Galcanezumab: a humanized monoclonal antibody for the prevention ofmigraine and cluster headache","year":2020,"lang":"en","type":"article","venue":"Drugs of today","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Migraine; Medicine; Triptans; Calcitonin gene-related peptide; Cluster headache; Chronic Migraine; Headaches; Clinical trial; Rizatriptan; Pharmacology; Bioinformatics; Internal medicine; Sumatriptan; Receptor; Psychiatry; Neuropeptide","authors":[{"name":"Michael H. Ossipov","is_ca":false},{"name":"Robert B. Raffa","is_ca":false},{"name":"Joseph V. Pergolizzi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03827635726970599,"gpt":0.3370591633159204,"spread":0.2987828060462144,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002591618,0.0001190405,0.0003203723,0.00002991697,0.0001054767,0.00000857968,0.00006657212,0.00004491652,0.00006725313],"category_scores_gemma":[0.0002027016,0.00007623414,0.0001642522,0.00008340745,0.00009464422,0.00003920375,0.00006221234,0.000105622,0.000003402417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009342285,"about_ca_system_score_gemma":0.00004361804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007126826,"about_ca_topic_score_gemma":0.00003267303,"domain_scores_codex":[0.999215,0.00002530053,0.000248107,0.0001861389,0.0001659601,0.0001595077],"domain_scores_gemma":[0.9993938,0.0002069651,0.00008644213,0.0001409048,0.0001001571,0.00007168215],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006110166,0.0006590533,0.01349569,0.003517357,0.00217327,0.00001107253,0.05209778,0.0000114822,0.09152832,0.00704205,0.8045493,0.01880439],"study_design_scores_gemma":[0.02856384,0.005569372,0.09348611,0.0007271483,0.002584606,0.00006542754,0.01351794,0.01651358,0.01715119,0.00217346,0.8188173,0.0008299909],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8589442,0.00661946,0.002901275,0.1245287,0.00003797219,0.002229686,0.00005189128,0.00007394266,0.004612832],"genre_scores_gemma":[0.9912788,0.0002430045,0.001583209,0.002339788,0.0003077803,0.00004184772,0.00004146565,0.0000176182,0.004146532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1323345,"threshold_uncertainty_score":0.3108738,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4322495836","doi":"10.1358/dot.2023.59.3.3521858","title":"Cenegermin for the treatment of dry eye disease","year":2023,"lang":"en","type":"review","venue":"Drugs of today","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Tropomyosin receptor kinase A; Nerve growth factor; Clinical trial; Disease; Authorization; Intensive care medicine; Ophthalmology; Internal medicine; Receptor","authors":[{"name":"Giulia Coco","is_ca":false},{"name":"Giulia Piccotti","is_ca":false},{"name":"Vito Romano","is_ca":true},{"name":"Lorenzo Ferro Desideri","is_ca":false},{"name":"Aldo Vagge","is_ca":false},{"name":"Carlo Enrico Traverso","is_ca":false},{"name":"Marco Pellegrini","is_ca":false},{"name":"Alice Bruscolini","is_ca":false},{"name":"Marco Marenco","is_ca":false},{"name":"Giuseppe Giannaccare","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05328641506398813,"gpt":0.3666833527670074,"spread":0.3133969377030193,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001250401,0.0002318757,0.001317175,0.00007616811,0.00002857587,0.000003665406,0.000133931,0.000100129,0.00003248636],"category_scores_gemma":[0.00005633033,0.0001230737,0.001224551,0.0001312065,0.00004302991,0.00001251298,0.00002055922,0.00005901176,0.00003879747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006354312,"about_ca_system_score_gemma":0.0003298729,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004696806,"about_ca_topic_score_gemma":0.000004395109,"domain_scores_codex":[0.9989761,0.00003645663,0.0004229214,0.0002023087,0.0001916592,0.0001705229],"domain_scores_gemma":[0.9984984,0.0004592701,0.0002517705,0.0006345452,0.00006207611,0.00009389441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004444543,0.0002334535,0.000266117,0.01933793,0.0007754045,0.00001332297,0.000151089,3.354473e-7,7.197096e-7,0.0001142012,0.00007930386,0.9789837],"study_design_scores_gemma":[0.0004704662,0.0002220179,0.0002272816,0.006807556,0.00503501,4.422488e-8,0.00005479997,0.000006142845,0.00002247228,0.00001948199,0.9870344,0.0001003453],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002525556,0.9969336,0.000007970359,0.000189061,0.0002258661,0.001797507,0.0003880457,0.00002228765,0.0001831105],"genre_scores_gemma":[0.00007606475,0.989126,0.0000579342,0.00001978384,0.0001690253,0.0002385821,0.0001706522,0.00005425312,0.01008771],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9869551,"threshold_uncertainty_score":0.5018799,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4200565889","doi":"10.1358/dot.2021.57.12.3352760","title":"Delgocitinib in atopic dermatitis","year":2021,"lang":"en","type":"review","venue":"Drugs of today","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Tacrolimus; Calcineurin; Pimecrolimus; Janus kinase; Clinical trial; Dermatology; Safety profile; Ciclosporin; Pharmacology; Quality of life (healthcare); Pharmacokinetics; Janus kinase inhibitor; Adverse effect; Immunology; Transplantation; Internal medicine; Cytokine","authors":[{"name":"Johne Ho","is_ca":true},{"name":"Sonja Molin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02845163800676103,"gpt":0.3400481662397611,"spread":0.311596528233,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009102388,0.0002035552,0.001860362,0.000184764,0.00001549003,0.000005051694,0.0001276645,0.0002911868,0.0005441038],"category_scores_gemma":[0.0001797593,0.0001725964,0.0004726483,0.0002299903,0.00007434035,0.00003091899,0.00006167658,0.0002755328,0.00008512101],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003609007,"about_ca_system_score_gemma":0.0004188221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001713579,"about_ca_topic_score_gemma":0.000005026722,"domain_scores_codex":[0.998716,0.0001383773,0.0005876716,0.0002191182,0.0001523166,0.0001865046],"domain_scores_gemma":[0.999108,0.0002205448,0.0001810674,0.0003566496,0.00004953958,0.00008422713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000001252384,0.0001457383,0.0008855612,0.03340178,0.000170706,0.000801312,0.0001172923,4.252042e-8,2.184159e-8,0.0003266913,0.03375457,0.930395],"study_design_scores_gemma":[0.0003304853,0.000006361739,0.0004993005,0.02688006,0.0005251458,0.0002849837,0.00003293334,5.337632e-7,0.00000343471,0.0000482781,0.9712595,0.0001289643],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000107983,0.9859087,0.000001656045,0.0001723563,0.0001738127,0.0003119385,0.00004203204,0.00001942525,0.01326205],"genre_scores_gemma":[0.0005232489,0.9976839,0.0001275555,0.000304351,0.00006086941,0.00005128802,0.0003215825,0.00002325679,0.0009039391],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9375049,"threshold_uncertainty_score":0.7038277,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2053823757","doi":"10.1358/dot.2002.38.10.740195","title":"Identification of parkinsonism and Parkinson's disease","year":2002,"lang":"en","type":"review","venue":"Drugs of today","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Glenrose Rehabilitation Hospital","funders":"","keywords":"Parkinsonism; Medicine; Progressive supranuclear palsy; Parkinson's disease; Disease; Magnetic resonance imaging; Neuroimaging; Dopaminergic; Movement disorders; Physical medicine and rehabilitation; Psychiatry; Pathology; Radiology; Internal medicine; Dopamine","authors":[{"name":"Richard Camicioli","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02792266007442862,"gpt":0.3044069923022708,"spread":0.2764843322278422,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002192968,0.0004065001,0.001725413,0.0003020143,0.00004709688,0.0000150402,0.000156256,0.0001946425,0.0001202821],"category_scores_gemma":[0.00008938729,0.0003261814,0.0005820515,0.0002218063,0.0001203391,0.00006642741,0.0000756005,0.0001508927,0.0000429989],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006725678,"about_ca_system_score_gemma":0.0001736662,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001305228,"about_ca_topic_score_gemma":3.098149e-7,"domain_scores_codex":[0.9978319,0.0001012778,0.0008589469,0.000535931,0.0004384081,0.0002335345],"domain_scores_gemma":[0.9978814,0.00009484896,0.0008569561,0.0007038453,0.00009997573,0.0003629323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003796642,0.0005265848,0.0001066694,0.02223535,0.0004704024,0.00005517543,0.00006851302,7.78496e-8,0.000005374942,0.0002845305,0.0004602982,0.9757491],"study_design_scores_gemma":[0.000692314,0.00007079964,0.0008456545,0.007422506,0.0044743,0.00001329247,0.00001231103,0.00001763531,0.00005323147,0.0001640716,0.986012,0.0002218426],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007397283,0.9969559,0.00001632099,0.00004427178,0.0001670408,0.0009651083,0.0005409205,0.00003177524,0.0005388972],"genre_scores_gemma":[0.02115371,0.9769649,0.0001414467,0.00001915552,0.00007645934,0.0001243084,0.0002176757,0.00006100464,0.001241357],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9855517,"threshold_uncertainty_score":0.999919,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4294577824","doi":"10.1358/dot.2022.58.9.3422313","title":"Efficacy of vosoritide in the treatment of achondroplasia","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Achondroplasia; Medicine; Endocrinology; Natriuretic peptide; Internal medicine; Dwarfism; Mutation; NPR2; Fibroblast growth factor receptor 3; Guanosine; Mutant; Receptor; Genetics; Fibroblast growth factor; Gene; Biology; Surgery","authors":[{"name":"David M. Paton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01305993269531803,"gpt":0.2960372429706298,"spread":0.2829773102753118,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001583913,0.00005703366,0.0001231862,0.00005024132,0.00002215714,0.000001163679,0.0002151997,0.0000211184,0.00007339927],"category_scores_gemma":[0.00005636307,0.00004553573,0.00008030463,0.0001266507,0.00006386908,8.194031e-7,0.00006295352,0.00003891765,6.323788e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001446003,"about_ca_system_score_gemma":0.0000464149,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002164715,"about_ca_topic_score_gemma":0.00004469107,"domain_scores_codex":[0.9993219,0.0001334502,0.0001498099,0.000124416,0.0001699175,0.0001005349],"domain_scores_gemma":[0.9995555,0.0000653832,0.00005896041,0.000272247,0.00003623706,0.00001167595],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007980052,0.00290092,0.03814626,0.00005536017,0.0001368887,0.000007413325,0.006308454,0.0004678903,0.9152518,0.0004895922,0.001098862,0.03433858],"study_design_scores_gemma":[0.003645932,0.003423094,0.06376454,0.00001002193,0.00002242753,0.000005565353,0.005150767,0.00003200244,0.8636045,0.0001586226,0.06004732,0.0001352444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963133,0.001336833,0.000005318585,0.0002084111,0.00002459245,0.0002256394,0.00003959667,8.757415e-7,0.00184545],"genre_scores_gemma":[0.9994286,0.0001363031,0.0000294089,0.00001061747,0.0000125118,0.0000402309,0.00004193751,0.000006191211,0.0002941787],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05894845,"threshold_uncertainty_score":0.1856893,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003316205","doi":"10.1358/dot.2010.46.2.1464700","title":"Saxagliptin in type 2 diabetes","year":2010,"lang":"en","type":"article","venue":"Drugs of today","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Saxagliptin; Medicine; Glycemic; Metformin; Incretin; Type 2 diabetes; Hypoglycemia; Pharmacology; Diabetes mellitus; Internal medicine; Sitagliptin; Endocrinology","authors":[{"name":"Raquel Billiones","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006862667400269849,"gpt":0.2439676717201539,"spread":0.2371050043198841,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001237804,0.00006582162,0.0001615265,0.00009695011,0.000007406645,0.000003993726,0.00005392154,0.0000365732,0.0003484712],"category_scores_gemma":[0.00004900005,0.00005329637,0.00003745077,0.0001226354,0.00003012644,0.00003482167,0.00003200272,0.0000840691,0.00009015822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001016204,"about_ca_system_score_gemma":0.0000151952,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002126719,"about_ca_topic_score_gemma":0.00001904516,"domain_scores_codex":[0.9995266,0.000005861722,0.0001201689,0.0001021768,0.0001017877,0.0001434616],"domain_scores_gemma":[0.9996748,0.0000287448,0.00003262871,0.0001932689,0.00002811112,0.00004242786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001084009,0.001309039,0.6694132,0.0002618561,0.0002254985,0.0000239299,0.001116966,0.000003036002,0.100485,0.009369389,0.02364908,0.1940346],"study_design_scores_gemma":[0.004601578,0.0007077043,0.6036561,0.000223317,0.000226212,6.055268e-7,0.00026026,0.000219883,0.1402429,0.00104772,0.2485027,0.0003109649],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9491215,0.0001159383,2.203571e-7,0.0008250899,0.0002811375,0.0001561812,0.000001398429,0.00002149991,0.04947708],"genre_scores_gemma":[0.995718,0.00001809342,0.0006059244,0.0002116727,0.00005086694,0.000006985379,0.00001679519,0.000008910421,0.003362734],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2248536,"threshold_uncertainty_score":0.3815515,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117178293","doi":"10.1358/dot.2004.40.11.872578","title":"Efalizumab: Advancing psoriasis management with a novel, targetedT-cell modulator","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Psoriasis; Medicine; Pathogenesis; Monoclonal antibody; Immunology; Clinical trial; Monoclonal; Dermatology; Antibody; Plaque psoriasis; Pathology","authors":[{"name":"Kim Papp","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01323569622806394,"gpt":0.2490423389269608,"spread":0.2358066426988968,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003006564,0.0007923865,0.002112882,0.0003983629,0.0001461937,0.00001499873,0.0005578967,0.0005957403,0.0003445562],"category_scores_gemma":[0.00001328433,0.0005777818,0.0006787325,0.0003967317,0.000125558,0.00009161801,0.0001661842,0.0002949635,0.0003024563],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003479577,"about_ca_system_score_gemma":0.0003158697,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008005888,"about_ca_topic_score_gemma":0.000007887474,"domain_scores_codex":[0.9975169,0.00014794,0.0007749234,0.0007665271,0.0001421217,0.0006515971],"domain_scores_gemma":[0.9981795,0.0001297325,0.0007072454,0.000828618,0.00009950004,0.0000554336],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000125498,0.0006606398,0.000004567117,0.01914015,0.003256589,0.00004327972,0.0002594403,0.00002053885,0.00009628411,0.0006294167,0.001050805,0.9747128],"study_design_scores_gemma":[0.002938014,0.0002024772,0.00000538624,0.009789038,0.004191254,0.00005151217,0.0000906917,1.345178e-7,0.000980658,0.00002587281,0.9810862,0.0006387805],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001585588,0.9925759,0.0001360633,0.00001135569,0.0009832344,0.001147415,0.0007360142,0.0001039759,0.004147494],"genre_scores_gemma":[0.0005797456,0.9907448,0.002013124,0.00001722088,0.00006781987,0.0002566464,0.0008727997,0.0001193135,0.005328537],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9800354,"threshold_uncertainty_score":0.9996673,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2339145532","doi":"10.1358/dot.2015.51.10.2401004","title":"Tavaborole topical solution, 5% for the treatment of toenailonychomycosis","year":2015,"lang":"en","type":"review","venue":"Drugs of today","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Dermatology; Trichophyton rubrum; Erythema; Nail (fastener); Clinical trial; Adverse effect; Antifungal; Dermatophyte; Internal medicine","authors":[{"name":"Lee T. Zane","is_ca":false},{"name":"J. J. PLATTNER","is_ca":false},{"name":"Sanjay Chanda","is_ca":false},{"name":"Dina Coronado","is_ca":false},{"name":"Tejal Merchant","is_ca":false},{"name":"Aditya K. Gupta","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06903558764533257,"gpt":0.3846905140682847,"spread":0.3156549264229521,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000804029,0.0002510258,0.00142116,0.00006462639,0.00003658237,0.000004548027,0.0001208298,0.0001333476,0.00006416398],"category_scores_gemma":[0.00003793908,0.0001262169,0.0009804105,0.0001118705,0.00006924482,0.00001763519,0.00001832613,0.00004306327,0.00001669168],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001838855,"about_ca_system_score_gemma":0.0003535271,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001000161,"about_ca_topic_score_gemma":0.000003554606,"domain_scores_codex":[0.9988729,0.00003432176,0.0004608763,0.000219184,0.0002337694,0.0001789741],"domain_scores_gemma":[0.9986575,0.00023453,0.0002799908,0.0005270483,0.0001781288,0.0001227949],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007703307,0.001001002,0.0000530955,0.003835644,0.001039588,0.00000236219,0.00009186474,8.196997e-8,1.477933e-7,0.0001221743,0.006525305,0.9872517],"study_design_scores_gemma":[0.001516282,0.001049073,0.00005949331,0.001830849,0.006863755,0.000004501622,0.00001993841,0.000005748107,0.000008413578,0.00005340882,0.9885007,0.00008784253],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003586933,0.9965391,0.00002508065,0.0002128764,0.0002036656,0.001864372,0.0004730888,0.00001237753,0.0006335424],"genre_scores_gemma":[0.0001896899,0.996215,0.0003140771,0.00001666077,0.0002161815,0.0003900811,0.0002610485,0.00002877228,0.002368528],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9871638,"threshold_uncertainty_score":0.5146975,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2029669980","doi":"10.1358/dot.2009.45.1.1315920","title":"Strategies to preserve prostate health","year":2009,"lang":"en","type":"review","venue":"Drugs of today","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital","funders":"","keywords":"Medicine; Prostate cancer; Prostatitis; Prostate Diseases; Clinical trial; Prostate; Etiology; Prostate disease; Intensive care medicine; Bioinformatics; Cancer; Pathology; Internal medicine","authors":[{"name":"Mischel G. Neill","is_ca":true},{"name":"Sree Appu","is_ca":false},{"name":"Alexandre R. Zlotta","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04537611585843949,"gpt":0.3922815173844368,"spread":0.3469054015259973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002366497,0.0003796388,0.002263632,0.0001842908,0.00003660319,0.00003008264,0.0001646224,0.0001147315,0.00005760297],"category_scores_gemma":[0.00002076407,0.0002628445,0.0004330917,0.0002698753,0.00003119612,0.00006774324,0.0000618722,0.0002049276,0.00006782433],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003354866,"about_ca_system_score_gemma":0.001556202,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002046975,"about_ca_topic_score_gemma":0.00001336268,"domain_scores_codex":[0.9980881,0.00007313615,0.0007177374,0.0004289437,0.0003129998,0.0003791151],"domain_scores_gemma":[0.9985485,0.00006905199,0.0003969541,0.0005813949,0.00009738041,0.0003067147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002015992,0.0002354178,0.00000533821,0.02273367,0.000214568,0.00002126897,0.0004744568,0.000001184903,6.546752e-8,0.0003300756,0.02290905,0.9530547],"study_design_scores_gemma":[0.0003889585,0.001292648,0.00005014626,0.03256539,0.0004060945,0.00001059358,0.00009754907,1.773123e-7,0.000009801858,0.00009886451,0.9649043,0.0001754714],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001220871,0.9887825,0.00000262863,0.002146211,0.0001238833,0.003136601,0.0002698225,0.00004682116,0.005479313],"genre_scores_gemma":[0.00004841914,0.9968423,0.0005326869,0.0004054167,0.0001156569,0.0003670503,0.0003417229,0.0000461603,0.001300646],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9528793,"threshold_uncertainty_score":0.9999824,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2398096896","doi":"10.1358/dot.2015.51.12.2420391","title":"Patiromer: A significant advance in the management of hyperkalemia","year":2015,"lang":"en","type":"review","venue":"Drugs of today","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Hyperkalemia; Medicine; Spironolactone; Kidney disease; Heart failure; Aldosterone; Adverse effect; Internal medicine; Urology","authors":[{"name":"David M. Paton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02952100010733287,"gpt":0.3355143980820784,"spread":0.3059933979747455,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005334238,0.000228948,0.001277647,0.0001633546,0.00001044112,0.000002271925,0.0003013646,0.0001861718,0.00003420801],"category_scores_gemma":[0.00001741184,0.0001236757,0.0003064,0.0004070492,0.0001032615,0.0000241957,0.0000553088,0.0003336584,0.0000270419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005318869,"about_ca_system_score_gemma":0.000143679,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002667696,"about_ca_topic_score_gemma":7.370986e-7,"domain_scores_codex":[0.9984171,0.0001043799,0.0006534266,0.0002202182,0.0004138566,0.00019103],"domain_scores_gemma":[0.9989014,0.00007917424,0.0003729645,0.0005423965,0.00004963201,0.00005440949],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001620672,0.0002434359,0.000009018443,0.02924732,0.0002648024,0.00006109468,0.0004177568,0.000001516381,6.369457e-7,0.0002802704,0.002396975,0.967061],"study_design_scores_gemma":[0.0006644865,0.0000770343,0.00003280172,0.01698227,0.001262449,0.00001125807,0.0006147279,0.000001490883,0.000001307874,0.00006688601,0.9801615,0.0001237673],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007399379,0.9561982,0.000002278608,0.0001009697,0.0001056922,0.001009603,0.00003115206,0.000008617906,0.04246953],"genre_scores_gemma":[0.0005589435,0.9983223,0.0002332635,0.00003495773,0.0000199127,0.00007375873,0.00007088344,0.00002489391,0.000661073],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9777645,"threshold_uncertainty_score":0.5043349,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2412549228","doi":"10.1358/dot.2015.51.6.2339112","title":"American Psychiatric Association - 168th Annual Meeting (May 16-20,2015 - Toronto, Canada)","year":2015,"lang":"en","type":"article","venue":"Drugs of today","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Psychiatry; Association (psychology); Addiction; Theme (computing); Gerontology; Psychotherapist; Psychology","authors":[{"name":"Alexandra Kibble","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01329601164486981,"gpt":0.2968485207447442,"spread":0.2835525090998744,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005556031,0.0001585291,0.0004123764,0.00005876938,0.00005458806,0.00001059224,0.000108658,0.00006220836,0.0001540088],"category_scores_gemma":[0.0006913215,0.000155405,0.00009301816,0.0002603996,0.00003457862,0.0002104346,0.00004267505,0.0001675733,0.00002021405],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00151866,"about_ca_system_score_gemma":0.0009052338,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4542475,"about_ca_topic_score_gemma":0.4258776,"domain_scores_codex":[0.9980102,0.000102437,0.0003485668,0.0002424212,0.0009870135,0.0003093845],"domain_scores_gemma":[0.998403,0.0001237322,0.0004834896,0.0002786648,0.000483266,0.0002279009],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001796096,0.0004445347,0.563517,0.00006193166,0.0002381695,0.000008150477,0.001997754,0.0001026593,0.0003440911,0.0001152349,0.422966,0.0100248],"study_design_scores_gemma":[0.008612377,0.001134448,0.2274186,0.0001741047,0.0009244807,0.00004621524,0.1558772,0.0006692125,0.0008416865,0.0001229582,0.6029404,0.001238296],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9316617,0.0007695814,0.0000444467,0.01028611,0.0005897388,0.0002491837,0.00008152189,0.00006397863,0.05625369],"genre_scores_gemma":[0.991874,0.00002108813,0.0006064392,0.0006259416,0.0002324298,0.000008432502,0.00006028579,0.00003008312,0.006541326],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3360984,"threshold_uncertainty_score":0.6337233,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2321447119","doi":"10.1358/dot.2011.47.6.1603439","title":"Tesamorelin: A novel therapeutic option for HIV/HAART-associatedincreased visceral adipose tissue","year":2011,"lang":"en","type":"article","venue":"Drugs of today","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Adipose tissue; Hormone; Glucose homeostasis; Endocrinology; Internal medicine; Homeostasis; Lipid profile; Obesity; Bioinformatics; Diabetes mellitus; Insulin resistance; Biology","authors":[{"name":"Julian Falutz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03736310445377607,"gpt":0.3154414242656713,"spread":0.2780783198118952,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001846162,0.0001358553,0.0002925885,0.0001089289,0.0001005604,0.000004710822,0.00008540372,0.0001302198,0.0001711061],"category_scores_gemma":[0.00004481873,0.0001189526,0.0001033615,0.0001396727,0.00004085874,0.00005440542,0.00001472317,0.000107745,0.0001141181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000987584,"about_ca_system_score_gemma":0.000106781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002837771,"about_ca_topic_score_gemma":0.000005491786,"domain_scores_codex":[0.9989913,0.00001906946,0.0003484554,0.0002258638,0.0001571723,0.0002581984],"domain_scores_gemma":[0.9990627,0.00009138732,0.0001750451,0.0002978319,0.0002215482,0.0001514891],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01192093,0.03833051,0.1697698,0.002801886,0.006858913,0.00006141945,0.04144895,0.00005386617,0.1876404,0.0794993,0.04699915,0.4146149],"study_design_scores_gemma":[0.04526211,0.006518931,0.7955425,0.001578961,0.003682411,0.0001029314,0.0009519853,0.01132901,0.04265739,0.007125852,0.08403126,0.00121668],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9467995,0.00184029,0.01097503,0.007730434,0.0004417652,0.004676132,0.0005356911,0.0003412403,0.0266599],"genre_scores_gemma":[0.987245,0.00004102832,0.009729998,0.0004479811,0.00007548051,0.000162421,0.0002238014,0.00003126903,0.002043041],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6257727,"threshold_uncertainty_score":0.4850745,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3120200411","doi":"10.1358/dot.2021.57.1.3233361","title":"Recombinant vesicular stomatitis virus expressing Ebola virusglycoprotein (rVSV-EBOV), a new Ebola vaccine","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women and Children’s Health Research Institute; University of Alberta","funders":"","keywords":"Ebola vaccine; Ebola virus; Virology; Vesicular stomatitis virus; Ebolavirus; Sierra leone; Outbreak; Medicine; Vaccination; Virus","authors":[{"name":"Zubia Mumtaz","is_ca":true},{"name":"Michael Hawkes","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01607867106629849,"gpt":0.2971816121544201,"spread":0.2811029410881216,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003734169,0.0002347524,0.0005884129,0.0002196172,0.0001605071,0.00006643921,0.0001437414,0.0001623191,0.001578271],"category_scores_gemma":[0.0002819496,0.0002062903,0.0002658986,0.0005075605,0.00004744589,0.0001948314,0.0001857201,0.0003971456,0.0001640408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001107463,"about_ca_system_score_gemma":0.0004577691,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002355893,"about_ca_topic_score_gemma":0.0001045948,"domain_scores_codex":[0.9978865,0.0001292633,0.0005336934,0.0004234182,0.000570156,0.0004569513],"domain_scores_gemma":[0.9985066,0.00008287915,0.0001421729,0.0006197609,0.000315284,0.0003332713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001648501,0.0004188016,0.0005052185,0.0002264373,0.0001492605,0.0003989963,0.0005418855,0.00001187039,0.8326529,0.0003277959,0.02060884,0.1439932],"study_design_scores_gemma":[0.002904274,0.0003346165,0.005176122,0.0007144649,0.00009638964,0.000202383,0.000254175,0.0003324008,0.8847486,0.0005222521,0.1044641,0.0002502101],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9759404,0.003809041,0.001418263,0.00319912,0.0005257251,0.0006364411,0.00002451552,0.0001413178,0.01430519],"genre_scores_gemma":[0.9745812,0.000475184,0.006056341,0.0004968822,0.0003931998,0.00004474365,0.00005899944,0.00007196997,0.0178215],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.143743,"threshold_uncertainty_score":0.9993344,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002072862","doi":"10.1358/dot.2006.42.9.996568","title":"Ropinirole treatment for restless legs syndrome","year":2006,"lang":"en","type":"review","venue":"Drugs of today","topic":"Restless Legs Syndrome Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Ropinirole; Restless legs syndrome; Medicine; Selegiline; Levodopa; Pramipexole; Placebo; Dopaminergic; Rotigotine; Population; Dopamine agonist; Dopamine; Pharmacology; Internal medicine; Parkinson's disease; Insomnia; Alternative medicine; Disease","authors":[{"name":"Miklos Z. Molnar","is_ca":false},{"name":"Katalin Fornadi","is_ca":false},{"name":"Colin M. Shapiro","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1143577149302418,"gpt":0.4339965283323711,"spread":0.3196388134021293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003950167,0.000641413,0.00397021,0.000621743,0.00007158861,0.00003126583,0.0004261683,0.0005504832,0.0001247257],"category_scores_gemma":[0.0001024512,0.0004580382,0.001545205,0.000405624,0.0001672235,0.0000617534,0.0001066996,0.000345139,0.0002049308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006510956,"about_ca_system_score_gemma":0.00111718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002997629,"about_ca_topic_score_gemma":0.000006852223,"domain_scores_codex":[0.9966248,0.0001429692,0.001096216,0.0007295892,0.0007120933,0.0006943684],"domain_scores_gemma":[0.9972637,0.0005636702,0.0004676084,0.001256638,0.0001872658,0.0002611399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005241872,0.000641049,0.00001736262,0.0646839,0.0007618855,0.000294121,0.00004013361,0.000001332377,0.000002854627,0.0003342059,0.007405532,0.9257652],"study_design_scores_gemma":[0.00135588,0.001022202,0.00004017335,0.01756699,0.001309145,0.0005810712,0.00001200417,0.00000531566,0.00002124544,0.00004147993,0.9777064,0.0003381516],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001655464,0.9876613,0.00001997586,0.0001963191,0.0002269544,0.003924278,0.0004218635,0.00006784197,0.007315936],"genre_scores_gemma":[0.0001304713,0.9664648,0.0006552892,0.000008333403,0.0002422559,0.0009950162,0.000996645,0.0001934068,0.03031376],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9703008,"threshold_uncertainty_score":0.9997872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4282918298","doi":"10.1358/dot.2022.58.6.3400572","title":"Bimekizumab for psoriasis","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Secukinumab; Psoriasis; Ustekinumab; Tolerability; Adalimumab; Adverse effect; Dermatology; Immunology; Immune system; Population; Internal medicine; Tumor necrosis factor alpha; Psoriatic arthritis","authors":[{"name":"Maria Alexandra Rodrigues","is_ca":false},{"name":"Egídio Freitas","is_ca":false},{"name":"Tiago Torres","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01460619210585043,"gpt":0.24055590479578,"spread":0.2259497126899296,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002138325,0.0001059152,0.0002159697,0.00009287397,0.0002504033,0.000002659986,0.0002090102,0.00006225929,0.001641214],"category_scores_gemma":[0.00002562137,0.00009942431,0.0001739207,0.0001080009,0.00004375229,0.00002992885,0.00009045308,0.00006765816,0.00007615561],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000361986,"about_ca_system_score_gemma":0.00004143249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004814853,"about_ca_topic_score_gemma":0.00000234691,"domain_scores_codex":[0.9992818,0.00009855236,0.0001861246,0.0001896965,0.00003355436,0.0002102831],"domain_scores_gemma":[0.9994529,0.0001792435,0.0001013457,0.000222598,0.00003294465,0.0000109004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002767705,0.001249591,0.002491524,0.00008403315,0.001822731,0.000006441995,0.005335229,0.00007404503,0.2384884,0.01456357,0.1264149,0.6067019],"study_design_scores_gemma":[0.005016774,0.0006074563,0.001754692,0.000006671706,0.0002536638,0.00001820564,0.001280159,0.000003923407,0.2748497,0.001155835,0.7148029,0.0002500268],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9842106,0.004532663,0.00007271987,0.0006333242,0.002904766,0.00052008,0.000884968,0.00008648548,0.006154385],"genre_scores_gemma":[0.98905,0.00002514944,0.0002491116,0.00008338087,0.00003802028,0.0002419412,0.0002862275,0.00001543768,0.0100107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6064518,"threshold_uncertainty_score":0.9992714,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4210789185","doi":"10.1358/dot.2022.58.1.3353167","title":"Estetrol and drospirenone: a novel oral contraceptive","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Drospirenone; Estrogen; Endocrine system; Estrogen receptor; Endometrial cancer; Agonist; Pharmacology; Endometrium; Internal medicine; Endocrinology; Gynecology; Physiology; Receptor; Cancer; Hormone; Breast cancer","authors":[{"name":"David M. Paton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01420952329394259,"gpt":0.279956472327496,"spread":0.2657469490335534,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003559926,0.00008318207,0.0002523703,0.00006888316,0.0001091537,0.000004084899,0.0000414169,0.00002692661,0.0002351593],"category_scores_gemma":[0.00009053906,0.00007737274,0.000048949,0.0001171787,0.00007452143,0.00005373437,0.00004758645,0.0001895106,0.000005058877],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005842467,"about_ca_system_score_gemma":0.00008561543,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001204562,"about_ca_topic_score_gemma":0.000002682608,"domain_scores_codex":[0.9991045,0.00003706818,0.0001990565,0.0002408445,0.0002441576,0.0001743834],"domain_scores_gemma":[0.9994799,0.00004307391,0.0001035016,0.000191471,0.00008367361,0.0000983233],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.006587033,0.003030669,0.1084555,0.0006460175,0.0003722573,0.00005506707,0.01604485,0.0001141495,0.387581,0.007300026,0.007874287,0.4619392],"study_design_scores_gemma":[0.02222723,0.005628581,0.803288,0.0001150938,0.0003828738,0.0003595297,0.00948465,0.001931528,0.01242352,0.0011196,0.1424222,0.0006171206],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917941,0.000766825,0.0002889117,0.004502738,0.0001896213,0.0005115393,0.00003124902,0.0000287075,0.001886287],"genre_scores_gemma":[0.9973114,0.00002211073,0.0005413605,0.0006489472,0.0001177188,0.00006702245,0.00001419347,0.00001183153,0.001265428],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6948326,"threshold_uncertainty_score":0.3155169,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3189922281","doi":"10.1358/dot.2021.57.8.3293588","title":"Vibegron: a beta3-adrenergic agonist for the treatment ofoveractive bladder","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Nocturia; Medicine; Overactive bladder; Anticholinergic; Agonist; Oxybutynin; Urology; Urinary urgency; Urinary incontinence; Anticholinergic agents; Urinary bladder; Adrenergic; Urinary system; Mirabegron; Internal medicine; Receptor; Pathology","authors":[{"name":"David M. Paton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02997721073690499,"gpt":0.3314776276383604,"spread":0.3015004169014553,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001552527,0.0001314244,0.0002676609,0.00003964985,0.0001329282,0.00002063187,0.00008307878,0.00005246004,0.0006026862],"category_scores_gemma":[0.00004780742,0.00007995139,0.0002328494,0.0001416775,0.00009829697,0.00005080278,0.00003830389,0.0001034888,0.00002299503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007847748,"about_ca_system_score_gemma":0.000331815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001387462,"about_ca_topic_score_gemma":0.00002115175,"domain_scores_codex":[0.9990028,0.00004662978,0.0001810886,0.0002330943,0.0002695617,0.0002668672],"domain_scores_gemma":[0.998722,0.0005066742,0.00005039331,0.0003978751,0.0002267381,0.0000963728],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01125465,0.01290449,0.006757481,0.001203709,0.01171638,0.00106795,0.03911892,0.0003183499,0.0784123,0.01001774,0.08103118,0.7461969],"study_design_scores_gemma":[0.006104803,0.002965131,0.008297634,0.0000751627,0.0006836118,0.0001029844,0.003799172,0.0006108513,0.3814734,0.0007984676,0.5948601,0.0002286904],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8163629,0.02170094,0.000629499,0.04644601,0.0007646077,0.003339697,0.0005728991,0.00009657717,0.1100869],"genre_scores_gemma":[0.967151,0.001905414,0.0005759759,0.0003005902,0.0002673636,0.000158536,0.0001326885,0.00002625417,0.02948217],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7459682,"threshold_uncertainty_score":0.6598991,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2804667058","doi":"10.1358/dot.2018.54.4.2795154","title":"Daclatasvir, asunaprevir and beclabuvir fixed-dose combination forpatients with genotype 1 chronic hepatitis C","year":2018,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Infectious Diseases Centre","funders":"","keywords":"Daclatasvir; Medicine; Internal medicine; Hepatitis C; Regimen; Hepatitis C virus; Virology; Adverse effect; Gastroenterology; Virus; Ribavirin","authors":[{"name":"Astou Thiam","is_ca":true},{"name":"Brian Conway","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03751225994869992,"gpt":0.3483131464482414,"spread":0.3108008864995414,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000557559,0.0005270781,0.002006136,0.000472488,0.0001170243,0.00004043341,0.0003400837,0.0004217197,0.0004401375],"category_scores_gemma":[0.000254567,0.0004011861,0.0002432455,0.0005194486,0.0004144042,0.0002033319,0.0002688648,0.0005999688,0.0002958914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005241841,"about_ca_system_score_gemma":0.00105874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000736438,"about_ca_topic_score_gemma":0.0002644903,"domain_scores_codex":[0.9967022,0.0002563016,0.0008510315,0.000691121,0.0009820608,0.0005172901],"domain_scores_gemma":[0.9975572,0.0002404947,0.000555173,0.0009441347,0.0004086026,0.0002944496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004888348,0.0001702845,0.001009748,0.02460943,0.0003760107,0.00003047191,0.0001402815,6.580336e-8,0.000002016689,0.0001094774,0.004306174,0.9691972],"study_design_scores_gemma":[0.001475557,0.001969266,0.0006055018,0.01993667,0.0008314164,0.0000284023,0.000003871926,0.00004634565,0.00002866872,0.00003009352,0.9746683,0.0003758538],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001836155,0.9900295,0.00002111155,0.00006572369,0.0001617522,0.00267011,0.0003716238,0.00005315638,0.004790882],"genre_scores_gemma":[0.002267207,0.9938934,0.0004846897,0.00004547234,0.0002084517,0.0001936762,0.001270697,0.00013836,0.001497997],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9703622,"threshold_uncertainty_score":0.999844,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3119281289","doi":"10.1358/dot.2021.57.1.3211618","title":"Apomorphine hydrochloride: A sublingual tablet for the OFF episodesin Parkinson's disease","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Apomorphine; Levodopa; Parkinson's disease; Disease; Pediatrics; Anesthesia; Dopamine; Internal medicine; Dopaminergic","authors":[{"name":"David M. Paton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01834182986100732,"gpt":0.2748438631171107,"spread":0.2565020332561034,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000251044,0.0002198572,0.0003954037,0.00006657776,0.000148162,0.00002853463,0.0001463025,0.0000592832,0.000305122],"category_scores_gemma":[0.0003864342,0.0001538421,0.0003155104,0.0002360714,0.00007311404,0.00007495556,0.00007366647,0.0001005924,0.00002380912],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005753354,"about_ca_system_score_gemma":0.0003929487,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000483062,"about_ca_topic_score_gemma":0.000008329308,"domain_scores_codex":[0.9985382,0.00003468849,0.0002887202,0.0003965528,0.0003938983,0.0003479248],"domain_scores_gemma":[0.9984159,0.000276728,0.0001335889,0.000604343,0.000242864,0.000326544],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03132253,0.02378235,0.1124108,0.005210946,0.01162897,0.008134983,0.004815836,0.0008342674,0.05828759,0.04829159,0.2135034,0.4817767],"study_design_scores_gemma":[0.007214926,0.0002295741,0.03177062,0.0002359374,0.001515736,0.00003321311,0.0003245602,0.003435206,0.05824101,0.002698814,0.8939884,0.0003119943],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9619064,0.0164853,0.001749953,0.01503018,0.0008021664,0.001441811,0.0009770832,0.0001144447,0.001492636],"genre_scores_gemma":[0.9923852,0.0003955395,0.001130086,0.0009391748,0.0003462892,0.00016582,0.0002924182,0.00004237448,0.004303091],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.680485,"threshold_uncertainty_score":0.6273499,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4246551118","doi":"10.1358/dot.2015.051.06.2339112","title":"American Psychiatric Association - 168th Annual Meeting (May 16-20, 2015 - Toronto, Canada)","year":2015,"lang":"en","type":"article","venue":"Drugs of today","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Association (psychology); Psychiatry; Family medicine; Environmental health","authors":[{"name":"Angel Kibble","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006765480933943373,"gpt":0.2606537743979496,"spread":0.2538882934640062,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002972469,0.0001343708,0.0003115339,0.00003454164,0.00004311117,0.000006316011,0.00007800363,0.00004436214,0.00006381475],"category_scores_gemma":[0.000111958,0.0001167706,0.00007050003,0.0001491109,0.00002319151,0.000082586,0.00002680067,0.0000897721,0.000009823128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001344995,"about_ca_system_score_gemma":0.0007216897,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7030875,"about_ca_topic_score_gemma":0.7984918,"domain_scores_codex":[0.9986362,0.00005450996,0.0002451524,0.0001822486,0.0006236547,0.0002581616],"domain_scores_gemma":[0.9990573,0.00004983133,0.0002418837,0.0002133177,0.0002176225,0.0002200603],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001064254,0.0003346944,0.73149,0.00003156962,0.0002691952,0.000003054537,0.001577656,0.000008121021,0.00003423123,0.00009930955,0.2488675,0.0171783],"study_design_scores_gemma":[0.006962565,0.001394643,0.3374316,0.00008331548,0.0008855732,0.00001800759,0.02080042,0.00008873611,0.001452853,0.0002106412,0.6300816,0.0005900341],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6190106,0.02588927,0.00003824587,0.02062158,0.001644216,0.0008009926,0.0004457996,0.0001503181,0.331399],"genre_scores_gemma":[0.9949873,0.00008460019,0.0005862041,0.0002678875,0.0001787949,0.00000844795,0.0000822002,0.00001942217,0.003785148],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3940583,"threshold_uncertainty_score":0.4761768,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2410968598","doi":"10.1358/dot.2004.40.7.850479","title":"Recent developments in lipid-lowering therapy - Highlights from theAtorvastatin Landmark Program: Global Investigators Meeting III","year":2004,"lang":"en","type":"article","venue":"Drugs of today","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Atorvastatin; Medicine; Landmark; Guideline; Clinical trial; Clinical Practice; Modalities; Medical physics; Family medicine; Pharmacology; Pathology; Artificial intelligence; Computer science","authors":[{"name":"Prabirkumar Bandyopadhyay","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01544992483414326,"gpt":0.2747528325590962,"spread":0.2593029077249529,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005899433,0.0002034978,0.0005009715,0.00007067883,0.0000590458,0.00001717209,0.0001303353,0.0001093375,0.00002824046],"category_scores_gemma":[0.00006296566,0.0001594272,0.0001330639,0.0003811787,0.00005397591,0.00007377139,0.00005209331,0.0001553965,0.000009287612],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000326578,"about_ca_system_score_gemma":0.0004794431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004346543,"about_ca_topic_score_gemma":0.000194599,"domain_scores_codex":[0.9981783,0.00006203908,0.0004896227,0.0003366098,0.0005655311,0.0003679064],"domain_scores_gemma":[0.9991878,0.00002245928,0.0001271698,0.0003537828,0.00008358842,0.0002251907],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.000485947,0.0007085108,0.06079326,0.000143195,0.0004598029,0.00008161079,0.004769878,0.00005975738,0.001808316,0.0004221084,0.000205142,0.9300625],"study_design_scores_gemma":[0.03377271,0.0008585689,0.4349658,0.004241677,0.0001384829,0.00003458997,0.001838496,0.00002372362,0.2010129,0.002148598,0.31989,0.001074449],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917538,0.002119636,0.00001858218,0.00108122,0.0002776389,0.0008894343,0.00001029427,0.0000881149,0.003761243],"genre_scores_gemma":[0.9877288,0.00200524,0.009465068,0.0004193414,0.0002095999,0.00008032114,0.00004805972,0.00002578419,0.00001782382],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.928988,"threshold_uncertainty_score":0.6570701,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2327987781","doi":"10.1358/dot.2014.50.1.2118308","title":"A report from the 16th IGPA conference (December 9-11, 2013 -Brussels, Belgium)","year":2014,"lang":"en","type":"article","venue":"Drugs of today","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Alliance; Medicine; Negotiation; Member states; Economic growth; International trade; Political science; Business; Law","authors":[{"name":"Mary Jean Bowman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04266725827465574,"gpt":0.2673820248804933,"spread":0.2247147666058376,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008340511,0.0001803581,0.0004752299,0.00006560413,0.00008830991,0.00007574691,0.0005325808,0.0001099101,0.002033943],"category_scores_gemma":[0.0002001361,0.0001601143,0.0001730107,0.0001076208,0.0001345119,0.000158008,0.0001481036,0.0001782352,0.001058392],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003712943,"about_ca_system_score_gemma":0.00003653784,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0041257,"about_ca_topic_score_gemma":0.0003052769,"domain_scores_codex":[0.9983769,0.00002824924,0.0008106444,0.0004142036,0.00004416306,0.0003258338],"domain_scores_gemma":[0.9982681,0.0002878971,0.0005306897,0.0007280341,0.00004355122,0.0001417446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002934696,0.0001640826,0.05265167,0.00002687091,0.0001647926,0.000005231296,0.001191752,0.0001034269,0.0001025323,0.6882652,0.253209,0.004086115],"study_design_scores_gemma":[0.0004652607,0.000015164,0.01442848,0.00001358971,0.00001187951,0.000004017184,0.00002978121,0.004414522,0.0004622772,0.08874575,0.8911743,0.0002349549],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6917892,0.001326592,0.001135095,0.03353388,0.001270502,0.0003148059,0.0006638777,0.0000510935,0.269915],"genre_scores_gemma":[0.9937638,0.0003209885,0.0003176413,0.003006716,0.0003852432,0.00001796096,0.00004561506,0.00002588382,0.002116161],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6379653,"threshold_uncertainty_score":0.9997194,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2442538157","doi":"10.1358/dot.2015.51.5.2336329","title":"A report from the American Association of Urology Annual Meeting2015 (May 15-19 - New Orleans, Louisiana, USA)","year":2015,"lang":"en","type":"article","venue":"Drugs of today","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Convention; Quarter (Canadian coin); Gerontology; Family medicine; Library science; Archaeology","authors":[{"name":"X Rabasseda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01935715254727123,"gpt":0.3010949530022958,"spread":0.2817378004550246,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005060239,0.0001256291,0.0004517781,0.0000437452,0.00002358649,0.000004556995,0.0001334102,0.00006816602,0.0001114187],"category_scores_gemma":[0.0007433339,0.000087524,0.0001078181,0.000186559,0.00009437869,0.00004801699,0.00004239479,0.0001235385,0.00002929032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001405752,"about_ca_system_score_gemma":0.0005429363,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02670734,"about_ca_topic_score_gemma":0.0004989119,"domain_scores_codex":[0.9986186,0.0001032006,0.0003804222,0.0002188908,0.0004831438,0.0001957396],"domain_scores_gemma":[0.998395,0.0001994988,0.0006237803,0.0003920395,0.0002050803,0.0001846324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006192627,0.0001769115,0.584323,0.000008956731,0.0004543921,0.00005156992,0.005634247,0.0000129417,0.0003465266,0.00003751923,0.3994229,0.008911781],"study_design_scores_gemma":[0.006187893,0.001582745,0.4793979,0.00006192367,0.001126681,0.00005276706,0.003702936,0.00002522701,0.004760047,0.001069074,0.5017753,0.0002574728],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9578,0.001066208,0.00008357524,0.02462211,0.0004360884,0.0003804789,0.0002421134,0.00003665422,0.01533276],"genre_scores_gemma":[0.9926128,0.00003821085,0.0006032295,0.001518268,0.0003843851,0.000006598541,0.00006790201,0.00001880402,0.004749777],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1049251,"threshold_uncertainty_score":0.9797739,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2334764107","doi":"10.1358/dot.2013.49.9.2056599","title":"A report from the European Society of Cardiology Congress 2013(August 31-September 4, 2013 - Amsterdam, The Netherlands)","year":2013,"lang":"en","type":"article","venue":"Drugs of today","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Attendance; Session (web analytics); Canadian Cardiovascular Society; Convention; Alternative medicine; Medical education; Preclinical research; Family medicine; Medical physics; Internal medicine; Myocardial infarction; Pathology; Law; Political science","authors":[{"name":"X Rabasseda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01110543531327187,"gpt":0.2360079853277723,"spread":0.2249025500145004,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007322609,0.0001645061,0.0005156942,0.00001354436,0.00007685689,0.00001660771,0.0002782959,0.00008560072,0.0002802535],"category_scores_gemma":[0.00003102686,0.00008591003,0.0009363517,0.0000845606,0.0003300306,0.00006282279,0.0001837482,0.0002368596,0.0001185203],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001070052,"about_ca_system_score_gemma":0.00005050009,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001789788,"about_ca_topic_score_gemma":0.000009777709,"domain_scores_codex":[0.998481,0.0003365038,0.0003959039,0.0002631577,0.0003119633,0.0002114142],"domain_scores_gemma":[0.9981497,0.0002086303,0.0002246955,0.001151811,0.0001664225,0.00009874759],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.00003707258,0.0000414168,0.05157461,0.00004215707,0.001974573,0.00004178188,0.0005274467,0.00004191028,0.002309283,0.000005717495,0.9408664,0.002537599],"study_design_scores_gemma":[0.001703675,0.00005036763,0.6916355,0.0001499471,0.001365548,0.0001476918,0.0009367577,0.00009370142,0.001916749,0.0001091913,0.3017009,0.0001899963],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9349548,0.00485224,0.0001127757,0.005494673,0.00041799,0.0007781838,0.00007231227,0.00003852368,0.05327852],"genre_scores_gemma":[0.9922314,0.0003410609,0.00008574301,0.0006506728,0.000742549,0.00002167678,0.00009946018,0.00002929731,0.005798182],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6400608,"threshold_uncertainty_score":0.3503309,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2526768593","doi":"10.1358/dot.2017.53.6.2662982","title":"Notable deals in the pharmaceutical industry in the first quarterof 2017","year":2017,"lang":"en","type":"review","venue":"Drugs of today","topic":"Competitive and Knowledge Intelligence","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Milestone; Medicine; Pharmaceutical industry","authors":[{"name":"E Cruces","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.171942251902463,"gpt":0.4050399365276934,"spread":0.2330976846252304,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001888671,0.0003020603,0.000821259,0.0002514184,0.0001679077,0.000311212,0.002220427,0.0003751523,0.0002277505],"category_scores_gemma":[0.0002243391,0.0001675246,0.0002693295,0.0003508818,0.0001405878,0.0003551528,0.0002480909,0.001460148,0.0005850524],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000294496,"about_ca_system_score_gemma":0.00006519884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005474109,"about_ca_topic_score_gemma":0.0006903448,"domain_scores_codex":[0.9983776,0.00008053117,0.0005915778,0.0003022489,0.0003055661,0.0003424677],"domain_scores_gemma":[0.9981728,0.0005181307,0.0004876904,0.0007383578,0.00007563988,0.000007360342],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000009488072,0.000306435,0.000880279,0.01004235,0.00004261191,0.00006404787,0.0007462509,0.000001022401,1.077107e-7,0.009635611,0.02852652,0.9497453],"study_design_scores_gemma":[0.0001109283,0.000004104476,0.0002358635,0.005947081,0.0001272134,0.000003929726,0.0003557723,0.00002472672,5.757688e-7,0.0002963418,0.9927017,0.0001917374],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001724194,0.8573987,0.000002531125,0.001410471,0.0004604613,0.0008152514,0.000009405057,0.00001089511,0.1397198],"genre_scores_gemma":[0.02045218,0.9753047,0.000004095749,0.001381735,0.001834101,0.0002045638,0.00003283004,0.00003420147,0.0007516409],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9641752,"threshold_uncertainty_score":0.751986,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4253960987","doi":"10.1358/dot.2016.52.10.2560079","title":"Notable deals in the pharmaceutical industry in the third quarterof 2016","year":2016,"lang":"en","type":"article","venue":"Drugs of today","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Pharmaceutical industry; Pharmacology","authors":[{"name":"E Cruces","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01796769573493584,"gpt":0.304380711128217,"spread":0.2864130153932811,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0009216644,0.00007706446,0.0001514452,0.00006911275,0.00003933836,0.000004067373,0.0002513231,0.002216475,0.00006275545],"category_scores_gemma":[0.0001048194,0.00002952142,0.00004217872,0.0001772773,0.0002048697,0.00003817807,0.00002490617,0.002657135,0.0000544765],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001565057,"about_ca_system_score_gemma":0.00004717644,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004113596,"about_ca_topic_score_gemma":0.00001574041,"domain_scores_codex":[0.99916,0.0001063358,0.0002297679,0.0001179566,0.0001525227,0.000233406],"domain_scores_gemma":[0.9991988,0.0004199907,0.00004465055,0.0002933582,0.0000177911,0.00002541388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00195185,0.002524411,0.1052045,0.0002163637,0.000345014,0.0005637442,0.01832235,0.000002813748,0.08523367,0.1025334,0.3421437,0.3409582],"study_design_scores_gemma":[0.01342793,0.0008623006,0.1022515,0.001850627,0.0001876002,0.0002574569,0.01196278,0.00008366925,0.1254499,0.007916518,0.7352756,0.0004740708],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6813842,0.00088813,0.00001317379,0.3008635,0.0001418573,0.0002450733,0.000002679282,0.00001913198,0.01644224],"genre_scores_gemma":[0.9955125,0.0006455158,0.00002059844,0.002507937,0.00004429225,0.00001391656,6.6788e-7,0.000004619735,0.00124996],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3931319,"threshold_uncertainty_score":0.9996438,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4252160329","doi":"10.1358/dot.2017.53.10.2746403","title":"Notable licensing deals in the biopharma industry in the thirdquarter of 2017","year":2017,"lang":"en","type":"article","venue":"Drugs of today","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Mergers and acquisitions; Pharmaceutical industry; Pharmacology; Finance; Business","authors":[{"name":"P D'Souza","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0631181787243877,"gpt":0.3970966101145358,"spread":0.3339784313901481,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003107735,0.00008074915,0.0002474542,0.000144774,0.0001023375,0.00002320929,0.0006447915,0.0001336002,0.0000512392],"category_scores_gemma":[0.0006065512,0.00003956626,0.0000475106,0.0001833645,0.0004161592,0.0001262574,0.00005632133,0.00067815,0.00000919076],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001604526,"about_ca_system_score_gemma":0.0001313268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00149244,"about_ca_topic_score_gemma":0.00008193193,"domain_scores_codex":[0.9986076,0.00009740219,0.0002606965,0.0001460355,0.0006095425,0.0002787403],"domain_scores_gemma":[0.9987004,0.0002518506,0.0001499852,0.0007589719,0.00008343786,0.0000553165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007140932,0.001433093,0.5514231,0.0006198331,0.00007127344,0.0005163412,0.1400329,0.00001279545,0.1529881,0.001372498,0.07196773,0.07884825],"study_design_scores_gemma":[0.00327606,0.0002598222,0.938185,0.0007695485,0.00003711833,0.00005206377,0.02149531,0.0002338376,0.0271714,0.0002141565,0.008205162,0.0001005396],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9472677,0.000251919,0.000001118323,0.01651947,0.0001140333,0.0003158814,0.000002389842,0.000003013848,0.03552454],"genre_scores_gemma":[0.9977428,0.00008122261,0.00004249934,0.001458796,0.0001445443,0.000006902169,0.000001371965,0.000004632456,0.0005172407],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3867619,"threshold_uncertainty_score":0.2946262,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4247809272","doi":"10.1358/dot.2018.54.2.2792548","title":"Life sciences licensing deals in the fourthquarter of 2017: updatesand trends","year":2018,"lang":"en","type":"article","venue":"Drugs of today","topic":"Academic Publishing and Open Access","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Mergers and acquisitions; Finance; Business","authors":[{"name":"P D'Souza","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1023021727966578,"gpt":0.4182660856357171,"spread":0.3159639128390592,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01191707,0.0001035468,0.0003076567,0.0005018258,0.0001686037,0.000294418,0.003089997,0.00009488151,0.0003299282],"category_scores_gemma":[0.004629947,0.0000555445,0.00008395752,0.001804136,0.0008017331,0.001275918,0.0002076032,0.000185073,0.00005633114],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007635166,"about_ca_system_score_gemma":0.0001438789,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002873144,"about_ca_topic_score_gemma":0.00006097083,"domain_scores_codex":[0.9967984,0.0003195497,0.000754791,0.0003467595,0.001508966,0.0002715568],"domain_scores_gemma":[0.9970145,0.001627807,0.0005059912,0.0005007972,0.0002643207,0.00008655857],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.00005270515,0.00009229163,0.05904688,0.000005311532,0.00001449206,0.000002006351,0.02043242,0.00004484252,0.0005832656,0.003946337,0.7813165,0.1344629],"study_design_scores_gemma":[0.002881465,0.0009152995,0.4084908,0.0004421197,0.00007062297,0.00003486133,0.0665488,0.009196969,0.02518748,0.08281204,0.4023291,0.001090404],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8863966,0.0002375469,0.00009927287,0.01219185,0.0003551605,0.00006293906,0.000009484804,0.000007847228,0.1006392],"genre_scores_gemma":[0.9974926,0.00001059837,0.0004613393,0.00124718,0.0001847321,0.000001576786,0.000001000799,0.000003790342,0.0005971586],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3789874,"threshold_uncertainty_score":0.5742034,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}